Ultrasensitive chemiluminescence bioassays based on microfluidics in miniaturized analytical devices by Zangheri, Martina
Alma Mater Studiorum – Università di Bologna 
 
 
DOTTORATO DI RICERCA IN 
 
CHIMICA 
 
Ciclo XXVII 
 
Settore Concorsuale di afferenza: 03/A1- CHIMICA ANALITICA 
 
Settore Scientifico disciplinare: CHIM/01-CHIMICA ANALITICA 
 
 
ULTRASENSITIVE CHEMILUMINESCENCE BIOASSAYS BASED ON 
MICROFLUIDICS IN MINIATURIZED ANALYTICAL DEVICES 
 
 
 
 
Presentata da: Zangheri Martina 
 
 
 
 
Coordinatore Dottorato     Relatore 
 
 
Chiar.mo Prof. Aldo Roda    Prof.ssa Mara Mirasoli 
 
 
 
 
 
Esame finale anno 2014/2015 
 
 
 
  
 
 
 
 
 
 
Alla mia famiglia 
1 
 
Indice 
 
CHAPTER 1: Introduction ........................................................................... 6 
1.1 Chemical Luminescence systems ....................................................... 9 
1.2 Biospecific molecular recognition reaction ...................................... 13 
1.2.1 Immunoassays ........................................................................... 13 
1.2.2 Gene probe hybridization assay ................................................. 16 
1.3 Microfluidic chip .............................................................................. 17 
1.3.1 Lateral Flow Immunoassay ........................................................ 21 
References ............................................................................................ 23 
CHAPTER 2: Aim of the thesis................................................................... 29 
CHAPTER 3: Gravitational field-flow fractionation integrated with 
chemiluminescence detection for a self-standing point-of-care compact 
device in bioanalysis ................................................................................. 34 
3.1 Introduction .................................................................................... 35 
3.2 Materials and methods ................................................................... 39 
3.2.1 Reagents ................................................................................... 39 
3.2.2 Samples ..................................................................................... 40 
3.2.3 GrFFF-CL POCT system ............................................................... 41 
3.3 Results and discussion ..................................................................... 45 
3.3.1 Principle of the assay/preliminary assays .................................. 45 
3.3.2 Method optimization ................................................................. 46 
3.3.3 Quantitative analysis ................................................................. 52 
3.3.4 Real samples analysis ................................................................ 57 
3.4 Conclusion ....................................................................................... 58 
References ............................................................................................ 60 
2 
 
CHAPTER 4: Portable chemiluminescence multiplex biosensor for 
quantitative detection of three B19 DNA genotypes ................................ 62 
4.1 Introduction .................................................................................... 63 
4.2 Materials and methods ................................................................... 66 
4.2.1 Oligonucleotide array biosensor ................................................ 66 
4.2.2 B19 probes and artificial targets ............................................... 66 
4.2.3 B19 amplified plasmid DNA and clinical samples ....................... 67 
4.2.4 Assay procedure ........................................................................ 67 
4.2.5 Data analysis ............................................................................. 69 
4.3 Results and discussion ..................................................................... 70 
4.3.1 Reaction chip optimization ........................................................ 70 
4.3.2 Calibration curves ...................................................................... 70 
4.3.3 Assay specificity ......................................................................... 71 
4.3.4 Analysis of amplified samples .................................................... 73 
4.4 Conclusion ....................................................................................... 73 
References ............................................................................................ 75 
CHAPTER 5: A multiplex chemiluminescent biosensor for type B-fumonisin 
and aflatoxin B1 quantitative detection in maize flour ............................. 77 
5.1 Introduction .................................................................................... 78 
5.2 Materials and methods ................................................................... 80 
5.2.1 Reagents ................................................................................... 80 
5.2.2 Preparation of mycotoxin-BSA conjugates ................................. 81 
5.2.3 Instrumentation ........................................................................ 82 
5.2.4 Assay procedure ........................................................................ 83 
5.2.5 Analysis of maize samples ......................................................... 85 
5.3 Results and discussion ..................................................................... 85 
5.3.1 Optimization of experimental parameters ................................. 86 
3 
 
5.3.2 Specificity of the immunoreagents ............................................ 88 
5.3.3 Calibration curves ...................................................................... 90 
5.3.4 Maize flour samples .................................................................. 93 
5.4 Conclusions ..................................................................................... 94 
References ............................................................................................ 97 
CHAPTER 6: A simple and compact smartphone accessory for quantitative 
chemiluminescence-based lateral flow immunoassay for salivary cortisol 
detection ................................................................................................ 100 
6.1 Introduction .................................................................................. 101 
6.2 Materials and methods ................................................................. 104 
6.2.1 Reagents ................................................................................. 104 
6.2.2 Preparation of immunochromatographic test strip ................. 104 
6.2.3 LFIA assay principle and format ............................................... 105 
6.2.4 Smartphone accessory ............................................................. 106 
6.2.5 Sample and spiked sample preparation ................................... 108 
6.2.6 Assay procedure ...................................................................... 108 
6.3Results and discussion .................................................................... 110 
6.3.1 Smartphone camera detectability and resolution .................... 110 
6.3.2 Concentration of immunoreagents .......................................... 112 
6.3.3 Chemiluminescent signal kinetics ............................................ 113 
6.3.4 Calibration curve ..................................................................... 114 
6.3.5 Determination of cortisol in real samples ................................ 115 
6.4 Conclusion ..................................................................................... 117 
References .......................................................................................... 118 
 
4 
 
CHAPTER 7: Multiwell cartridge with integrated array of amorphous silicon 
photosensors for chemiluminescence detection: development, 
characterization and comparison with cooled-CCD luminograph ........... 121 
7.1 Introduction .................................................................................. 122 
7.2 Materials and methods ................................................................. 124 
7.2.1 Reagents ................................................................................. 124 
7.2.2 Instrumentation ...................................................................... 125 
7.2.3 Photosensor array fabrication ................................................. 125 
7.2.4 Microwell cartridges fabrication .............................................. 128 
7.2.5 Chemiluminescence measurements ......................................... 128 
7.2.6 Cytotoxicity test ....................................................................... 130 
7.2.7 Total antioxidant activity measurements ................................ 131 
7.3 Results and discussion ................................................................... 131 
7.3.1 Photosensor characterization .................................................. 132 
7.3.2 Bio- and chemiluminescence measurements ........................... 135 
7.3.3 Alkaline phosphatase .............................................................. 137 
7.3.4 Luciferase ................................................................................ 140 
7.3.5 Horseradish peroxidase ........................................................... 141 
7.3.6 Sensors array characterization ................................................ 143 
7.3.7 Inter-sensor reproducibility...................................................... 144 
7.3.8 Crosstalk .................................................................................. 144 
7.3.9 Model luminescent bioanalytical assays .................................. 145 
7.3.10 Bioluminescence cytotoxicity assay ....................................... 145 
7.3.11 Chemiluminescence measurement of total antioxidant capacity
 ......................................................................................................... 146 
7.4 Conclusions ................................................................................... 148 
References .......................................................................................... 149 
5 
 
List of publications ................................................................................. 154 
Acknowledgments .................................................................................. 157 
 
 
 
 
 
 
 
  
6 
 
 
 
 
 
CHAPTER 1 
 
 
Introduction 
 
 
 
 
 
 
 
 
 
 
 
  
7 
 
The development of an accurate and user-friendly diagnostic device for 
point-of-care (POC) applications is one of the most challenging tasks in 
the field of analytical chemistry. The POC approach provides fast and 
reliable analytical results in a rapid and easy way. In order to be 
considered a real POC system, the device must fulfill minimum 
requirements [1], in particular it should: 
- allow the direct introduction of the sample with a minimum or nul 
sample pretreatment 
- be portable with a small size, reduced weigh and autonomous 
electrical power 
- be user-friendly in order to be used by non-skilled personnel outside 
well-equipped laboratories 
- offer qualitative or quantitative results, as required, by treating the 
primary measurement output provided by the detection system. 
Moreover an ideal POC device should be based on low cost and 
disposable elements and it should ensure stability and durability from 
the fabrication to their use. Other important characteristics of a POC 
device are the possibility to automate the analytical procedure (from 
sampling to results generation), to provide wide measurement range 
and multiplexing capability (simultaneous determination of multiple 
analytes), as well as device robustness, such as the tolerance to 
changes in air humidity and temperature [2].  
The possibility to scale down traditional bench-top analytical 
procedures and to transfer them in a portable miniaturized and self-
operating system can pave the way for extra-laboratory analyses in 
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clinical chemistry, environmental monitoring, food analysis, and bio-
warfare protection [3].  
The challenging objective in this field is the achievement of low limits 
of detection, since small sample volumes imply that only few molecules 
of analyte are available for detection, and the possibility to shorten 
time and cost of the analysis. The sensitivity of the device depends on 
the analytical technique employed for the recognition of the analyte 
and on the detection principle. Among the different analytical 
techniques, those based on biospecific molecular recognition reactions 
(like immunological or genic reactions) are suitable for this purpose, 
because of their high specificity and sensitivity, which makes it 
possible to detect analytes even at low concentrations and in complex 
matrices. By coupling these methods with optical detection it is 
possible to obtain high sensitivity, non-invasiveness, rapidity and easy 
implementation [4]. Among optical detection techniques, fluorescence 
is by far the most commonly employed one. On the other hand, 
chemical luminescence is particularly advantageous because it offers 
high detectability even in low volumes. Since excitation is not required, 
problems frequently encountered in photoluminescence, such as light 
scattering, source instability and high backgrounds due to unselective 
photoexcitation are absent in chemical luminescence [5,6]. Moreover 
the instrumentation for the measurment of chemical luminescence is 
very simple and it can be easily miniaturized, fitting the POC purposes. 
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1.1 Chemical Luminescence systems 
 
Chemical luminescence consists in the production of light via a 
chemical reaction and it can be distinguished in different subtypes 
depending on the type of stimulus able to trigger the reaction: 
chemiluminescence (CL) and bioluminescence (BL) are referred to the 
chemical production of light started by mixing the reagents, the latter 
exploiting enzymes and photoproteins isolated from living organisms 
[7]; electrogenerated chemiluminescence (ECL) is the luminescence 
generated by relaxation of exited state molecules produced during an 
electron-transfer reaction that occurs at the surface of an electrode [8]; 
thermochemiluminescence (TCL) is the emission of light produced by 
the thermally-induced decomposition of a molecule.  
For a chemical reaction to produce light, some essential requirements 
should be met [9]: 
1. To populate an electronically excited (singlet) state the reaction has 
to be sufficiently exergonic. The free energy requirement can be 
calculated using:  
 
Therefore, chemiluminescence reactions producing photons in the 
visible (400–750 nm) range require around 40–70 kcal mol-1.  
2. This electronically excited state has to be accessible on the reaction 
coordinate. 
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3. Photon emission from the excited state has to be a favorable energy 
release route. This means that either the product of the reaction has to 
be fluorescent or – if by energy transfer – an excited state can be 
populated (this energy transfer can occur intra- or intermolecularly). 
The chemical luminescence quantum yield, defined as the number of 
photons emitted per reacting molecule, can be expressed as: 
 
CL= R ES F 
 
where R reflects the chemical yield of the reaction, ES is the fraction 
of the product entering the excited state and F is the fluorescent 
quantum yield.  
 
The oxidation of luminol is one of the oldest described CL reactions.  
Luminol can be considered a diprotic acid with pKA of 6 and 13, 
respectively. During the CL reaction under basic conditions in presence 
of H2O2, luminol is oxidized to luminol radical anion in its excited state, 
which releases a photon while decaying to the ground state (Fig. 1). 
The light is emitted at 428 nm (blue light emission) with a relatively 
low quantum yield of 1% [10]. The reaction can be catalyzed by 
horseradish peroxidase (HRP) that is commonly used as a label in 
binding assays thanks to its signal amplification capability [7].  
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Figure 1: HRP-catalyzed oxidation of luminol. 
 
When enzyme labels are employed, care must be taken to avoid any 
situation in which the enzyme activity can be disrupted by 
experimental conditions and, as the enzyme activity depends on 
temperature, a thermostated read-out cell should be employed. The 
possibility to use an enzyme like horseradish peroxidase (HRP) or 
alkaline phosphatase (AP) as a label allows to amplify the CL signal, 
since in the presence of an excess of CL substrate many product 
molecules are generated from one enzyme molecule [11]. Moreover, 
the achievement of a steady-state of the CL emission allows the 
standardization of the experimental conditions and quantitation of the 
labeled probe under investigation, since the steady-state light intensity 
is directly related to the enzyme activity. Several efforts were 
dedicated to the improvement of the analytical performance of the 
HRP-catalyzed CL oxidation of luminol. Indeed it is possible to add to 
the CL cocktail some enhancers like p-iodophenol (PIP), 4- (1-
imidazolyl)phenol, [12] and other p-phenol derivatives, [13] para-
phenylphenol and sodium tetraphenylborate as synergistic enhancer, 
[14] or K3Fe(CN)6 as electron mediator [15]. These enhancers allow to 
amplify and stabilize the CL signal making it easier to measure the 
analytical signal [16].  
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The analytical interest of chemical luminescence detection techniques 
mainly arises from their ability to produce photons with no need for 
photoexcitation, as it occurs in fluorescence detection, thereby 
avoiding problems arising from light scattering, background 
fluorescence or light source instability. Therefore, instrumentation for 
chemical luminescence measurements is in principle very simple, since 
no excitation source is required. In addition, when chemical 
luminescence detection is employed in conjunction with imaging 
detection systems, such as charge coupled device (CCD) or 
complementary metal-oxide semiconductor (CMOS) cameras, flexible 
configurations of the reading cell (e.g., the spatial distribution of 
microarray spots on a functionalized surface) are possible, provided 
that cross-talk phenomena are controlled. Finally, chemical 
luminescence detection showed wide dynamic ranges, thus facilitating 
analysis of samples with very different analyte concentrations. On the 
other hand, the main pitfall of these detection techniques is the 
potential effect of sample matrix constituents on the chemical reaction, 
which can either enhance or inhibit the light producing reaction. These 
effects are by definition unpredictable, and may lead to artefacts or 
spurious results. Furthermore, due to the high detectability of the 
chemical luminescence labels, non-specific binding must be carefully 
controlled to avoid high background signals and thus surfaces 
functionalization strategies are crucial for the success of the assay [17]. 
Another aspect that needs to be taken into account, especially when 
signal acquisition is performed in a flow regimen, is the a kinetics of 
photons emission that varies depending on the chemistry employed 
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(ranging from flash- to glow-type). As the chemical luminescence 
signal is not stable over time, the light-emitting species are subjected 
to diffusion phenomena in solution, thus causing a loss in resolution 
[18].  
1.2 Biospecific molecular recognition reaction 
 
Molecular recognition refers to the specific interaction between two or 
more molecules that exhibit molecular complementarity [19,20]. 
Molecular recognition plays an important role in biological systems, 
such as the interaction between antigen-antibody or DNA-protein. 
These recognition is based on noncovalent bonding like hydrogen 
bonding, hydrophobic forces [21,22], van der Waals forces, π-π 
interactions, halogen bonding, electrostatic and/or electromagnetic 
effects. In addition to these direct interactions, the solvent can play a 
dominant indirect role in driving molecular recognition in solution. 
[23,24]. Molecular recognition reactions are usually exploited in the 
field of analytical chemistry as a sensitive and specific biosensing tools, 
allowing to generate assays that are widely applied for pharmaceutical 
analysis, toxicological analysis, bioanalysis, clinical chemistry, 
environmental and food analysis [25]. 
1.2.1 Immunoassays 
 
Immunoassays (IA) are well established bioanalytical methods widely 
employed for screening procedures offering high sample throughput, 
high sensitivity and reduced requirements for sample pre-analytical 
preparation, owing to the high specificity of antigen-antibody binding 
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reaction [3]. Appropriate antibodies bind with high selectivity to their 
antigen and it is possible to design IA for a wide range of analytes. The 
antibody is a protein that is able to recognize and bind selectively its 
own specific antigen by an affinity reaction. The chemical structure of 
the antigen allows its binding to the paratope of the antibody with high 
affinity, establishing an equilibrium reaction. This reaction depends on 
the concentration of the analytes if the antibody and the other reagents 
are present in constant concentrations. There are a great variety of 
antibodies that can be raised up for different kind of analytes such as 
small organic molecules (i.e. pesticides, hormones, pharmaceuticals or 
toxic small molecules), biopolymers (peptides, proteins, DNA) or the 
outer membrane of cells or organelles (viruses, bacteria, spores, fungi, 
protozoa, eukaryotic cells), thus allowing the development of rapid and 
sensitive immunoassay for biological, environmental or food analysis. 
Monoclonal (mAb) and polyclonal (pAb) antibodies are available for 
immunoassays [26]. Since the preparation of antibodies requires 
difficult and expensive procedures, recently, alternative recognition 
elements like recombinant antibodies (rAbs) or even artificial 
recognition elements like aptmers, have been developed with potential 
improved properties [27].  
The detection of the formed immune-complex is commonly performed 
through the use of labeled reagents. Nowadays, 80% of immunoassays 
for routine clinical analysis are based on the use of enzymatic labels 
[28]. Enzymes can be chemically coupled to primary detection 
antibodies, to antigens, to a secondary antibody (which binds to the 
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unlabelled primary antibody), or to streptavidin (which binds to 
biotinylated antibodies) to obtain enzymatic tracers. 
Immunoassays can be classified into competitive and non-competitive 
formats. While the non-competitive IAs (also known as “sandwich 
immunoassays”) are based on the directly detection of the immune-
complex, in the competitive format an analyte derivative is added and 
competes with the analyte present in the sample for binding to the 
antibody. The selection of the format depends on the analyte size, 
competitive immunoassays being applied for the detection of small 
analytes containing one binding site for antibody recognition, while 
sandwich immunoassays are applied to high molecular weight 
molecules that consist of two or more binding sites [29].  
Since the labelling process reduces the activity of antibodies, high 
amounts of antibodies are needed, which is expensive, especially for 
sensitive detection antibodies. So, as an alternative, it can be useful to 
label secondary antibodies (anti-human, anti-rabbit, anti-mouse, etc.) 
that react with unlabelled primary antibodies (human, rabbit, mouse, 
etc.) at the solid support. 
The most commonly immunoassay format for laboratory routine 
analysis is the microtiter plate-based immunoassay. This format uses a 
solid support for the antibody–antigen reaction and it requires the 
separation of the antibody-antigen complex from free antibodies. So 
the procedures are based on sequential reaction steps that provide the 
immunoreaction by adding sample and labelled reagents, the removal 
of matrix and unbound reagent through washing, and the detection 
step. The removal of unbound reagents by washing steps is very 
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important for the sensitivity of the assay because it can decrease 
significantly the background increasing the detectability.  
1.2.2 Gene probe hybridization assay 
 
Gene probe hybridization assays enable sensitive detection of target 
nucleic acid (DNA or RNA) sequences through their hybridization with 
complementary oligonucleotide probes immobilized on a 
functionalized surface. Nucleic acid hybridization is a fundamental tool 
in molecular genetics which takes advantage of the ability of individual 
single-stranded nucleic acid molecules to form double-stranded 
molecules. For this to happen, the interacting single-stranded 
molecules must have a sufficiently high degree of base 
complementarity. Standard nucleic acid hybridization assays involve 
the use of a labeled nucleic acid probe to identify related DNA or RNA 
molecules within a complex mixture. Nucleic acid hybridization assays 
are based on the interaction between a probe, which typically consists 
of a homogeneous population of identified molecules (e.g. cloned DNA 
or chemically synthesized oligonucleotides) and a target which 
typically consists of a complex, heterogeneous population of nucleic 
acid molecules. If either the probe or the target is initially double-
stranded, the individual strands must be separated, generally by 
heating or by alkaline treatment. After mixing single strands of probe 
with single strands of target, strands with complementary base 
sequences can be allowed to reassociate. By using a label that can 
evidence the hybridization between probe and target, it is possible to 
perform a hybridization assay. Traditionally, labeling of nucleic acids 
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has been conducted by incorporating nucleotides containing 
radioisotopes. Such radiolabeled probes contain nucleotides with a 
radioisotope (often 32P, 33P, 35S or 3H), which can be detected 
specifically in solution or, commonly, within a solid specimen. Another 
nonisotopic labeling widely used is the biotin-streptavidin system that 
utilizes the extremely high affinity of two ligands: biotin (a naturally 
occurring vitamin) which acts as the reporter, and the bacterial protein 
streptavidin, which is the affinity molecule. Biotinylated probes can be 
made easily by including a suitable biotinylated nucleotide in the 
labeling reaction. As for the immunoassay the commonly laboratory 
format used for hybridization assay is the microtiter plate-based that 
involves in immobilizing the target DNA on a solid support that binds 
the complementary single-stranded DNA readily. Attachment of 
labeled probe to the immobilized target DNA can then be followed by 
removing the solution containing unbound probe DNA, extensive 
washing and drying in preparation for detection [30]. Gene probe 
hybridization assays frequently take advantage of a preliminary PCR 
amplification of the target sequence to improve detectability (thanks to 
the exponential amplification factor of PCR) and specificity (joining the 
selective PCR amplification of target sequences with their subsequent 
specific capture by immobilized oligoprobes).  
1.3 Microfluidic chip 
 
Microfluidic technologies have a great potential for developing 
portable analytical devices due to the advantages in size, volume 
requirements and time for the analysis [31-35]. Traditional multiwell 
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plates format commonly used in laboratory analysis are based on the 
binding between the analytes in sample solution and the capture 
molecules immobilized on solid surfaces while the analytes not bound 
to the capture molecules are removed during washing steps. These 
methods usually need relatively long incubation times and several 
hours are required to complete an analysis (from 1 to 24h). This is 
mainly due to the fact that the rate of capture of analytes on 
functionalized solid surfaces is usually limited by the diffusion of 
analytes from the bulk phase to the boundary layer [36]. Microfluidic 
immunosensors are able to overcome this limitation, since the 
increased surface-to-volume ratio makes it possible to have a more 
efficient transport in the immunoreactions, leading to a faster analysis. 
Indeed under flow in microchannels, this transport process is thought 
to be kinetically rapid due to the proximity of the analytes to the 
surface, [37] and the rapid replenishment of depleted analytes in the 
boundary layer by convective flow (Fig.2) [38]. Moreover a 
miniaturized microchannel dimension provides the reduction of 
consumption of samples and reagents and automated integration with 
other functions, such as valves, pumps, mixers, and detectors allow 
achieving a POC goal [39,40]. For these reasons microfluidic systems 
have recently attracted great deal of attention as immunosensor 
platforms [41]. Microfluidic chips allow to develop arrays of specific 
capture probes on a functionalized surface, without impairing their 
binding ability. This system makes it also possible to perform multiplex 
analyses by spatially separating several reaction area, each of one 
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specific for a different analyte that is recognized by its specific 
position. 
Among the several material suited for functionalization and for the 
development of microfluidic chips, such as glass, silicon or polymer 
materials, the polydimethylsiloxane (PDMS) is characterized by simple 
fabrication process (e.g., molding, embossing and printing) and low 
cost [42,43]. Initially, PDMS proved to be particularly adapted for the 
development of microfluidic assays because of its flexibility, optical 
transparency, biocompatibility, and low-autofluorescence properties. 
Another advantage of PDMS is that it can be easily bonded to silicon, 
glass or PDMS itself through oxygen plasma treatment. Nowadays the 
technology improvements in the microfabrication in polystyrene and 
other plastics makes the use of PDMS less attractive [44]. 
Different methods can be employed to move liquids in microfluidics, 
such as pressure-driven flow, electro-osmosis, or acceleration. Ideal 
microfluidics are simple to utilize, reliable, fast, sensitive, versatile, and 
cheap. One of the simplest approaches for producing flow in 
microchannels is to use capillary forces [45]. Capillary-driven flow 
requires no peripheral equipment, and this concept is used for 
portable immunodiagnostic tests [46]. An emerging microfluidic 
platform based on capillary forces, are those based on porous 
materials, in which capillary action to generate the flow of fluids does 
not require external forces, like pumps or syringes. Hydrophobic 
barriers patterned into a porous, hydrophilic material provide 
channels for the controlled and autonomous wicking of fluids to testing 
zones within a device. These materials operate independently of 
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equipment and therefore make excellent substrates for the 
development of point-of-care diagnostic devices. Among porous 
materials, paper is an attractive substrate which allows producing 
diagnostic devices employing minimal infrastructure (e.g., a wax 
printer to pattern microfluidic channels and a pipette to dispense 
reagents) and inexpensive raw materials (ca. cents per device). In 
addition devices can be prototyped rapidly (ca. minutes from design to 
production) [47]. To date, a number of testing formats have been 
demonstrated using patterned paper devices, which include clinical 
chemistry assays [48-50], immunoassays [51], and electrochemical 
assays [52-54]. Paper-based microfluidics has become a dynamic area 
of research, but the majority of the activity in this field began only 
recently [55]. 
 
 
Figure 2: Schematic diagram of the differences between microtiter 
plate (A) and microfluidic channel (B) formats. 
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1.3.1 Lateral Flow Immunoassay 
 
Lateral Flow Immunoassays (LFIA) are based on the use of a 
nitrocellulose test strip as a migration membrane on which reagents 
are driven by capillary forces. Specific immunoreagents are 
immobilized in definite reactive areas, while a reporter probe, able to 
interact with the immobilized immunoreagents and to produce a 
detectable signal in response to the analyte presence, is deposited on a 
pad at one side of the strip. Traditionally the LFIA strip is composed by 
the assembly of different materials, each serving one or more purposes 
(Fig.3). The parts overlap onto one another and are mounted on a 
backing card using a pressure-sensitive adhesive [56]. When a test is 
run, sample is added to the proximal end of the strip, the sample pad. 
Here, the sample is treated to make it compatible with the rest of the 
test. The treated sample migrates through this region to the conjugate 
pad, where a reagent conjugated to a label has been immobilized. This 
label has been conjugated to one of the specific biological components 
of the assay, either antigen or antibody depending on the assay format. 
The sample re-mobilizes the dried conjugate, and the analyte in the 
sample interacts with the conjugate as both migrate into the next 
section of the strip, which is the reaction matrix. This reaction matrix is 
a porous membrane, typically nitrocellulose, onto which the other 
specific biological component of the assay has been immobilized. These 
are typically proteins, either antibody or antigen, which have been laid 
down in bands in specific areas of the membrane where they serve to 
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capture the analyte and the conjugate as they migrate by the capture 
lines. The areas in which the reagents are immobilized are called Test-
line (T-line), which is used for analyte detection, and Control-line (C-
line) that typically comprises a species-specific anti-immunoglobulin 
antibody, for capturing the excess of conjugated  detection 
immunoreagent. The signal on the C-line must always appear, 
confirming that the assay has been performed correctly. Finally the 
reagents move past the capture lines and are entrapped in the wick or 
absorbent pad. Results are interpreted on the reaction matrix as the 
presence or absence of signal in correspondence of T- and C-lines. The 
assay formats can be either non-competitive or competitive. Non-
competitive assays are typically used when testing for larger analytes 
with multiple antigenic sites and, in this case, a positive result is 
indicated by the presence of a test line. Competitive formats are 
typically used when testing for small molecules with single antigenic 
determinants, which cannot bind to two antibodies simultaneously. In 
this format, a positive result is indicated by the absence of a test line on 
the reaction matrix. In both non-competitive and competitive format, 
the C-line should appear, irrespectively of the result on the test line. 
The detection of the lines can be performed either by eye or using a 
reader, depending on the label used. In most cases, gold nanoparticles 
are employed as labels and results, usually obtained in the form of 
bands visible at the naked eye on the test strip, are readily available. 
Since conventional colorimetric LFIA only yield subjective and 
semiquantitative information and show limited sensitivity, various 
strategies were pursued to enhance analytical performance and to 
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obtain a quantitative information, including the use of different labels, 
such as paramagnetic particles, fluorescent dyes or chemiluminescent 
enzyme (e.g., HRP). Chemiluminescence LFIA were developed for 
cardiac troponin I [57], myoglobin [58], pathogen bacteria [59], 
explosives [60] and food contaminants  [61].  
 
 
Figure 3: Scheme of the LFIA strip. 
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The activity carried out during my PhD was principally addressed to 
the development of portable microfluidic analytical devices based on 
biospecific molecular recognition reactions and CL detection. In 
particular, the development of biosensors required the study of 
different materials and procedures for their construction, with 
particular attention to the development of suitable immobilization 
procedures, fluidic systems and the selection of the suitable detectors. 
Different methods were exploited, such as gene probe hybridization 
assay or immunoassay, based on different platform (functionalized 
glass slide or nitrocellulose membrane) trying to improve the 
simplicity of the assay procedure. Different CL detectors were also 
employed and compared with each other in the search for the best 
compromise between portability and sensitivity. The work was 
therefore aimed at miniaturization and simplification of analytical 
devices and the study involved all aspects of the system, from the 
analytical methodology to the type of detector, in order to combine 
high sensitivity with easiness-of-use and rapidity.  
in Chapter 3, an analytical device is proposed that is able to provide 
both the pre-analytical sample preparation and the analyitical step. In 
particular, an integrated POCT system based on gravitational field-flow 
fractionation (GrFFF) and CL detection is presented for the on-line 
sample pre-analytical treatment and/or clean-up and analysis of 
biological fluids. As a proof of principle for the new GrFFF-CL POCT 
system, the automatic on-line analysis of plasma alkaline phosphatase 
activity, a biomarker of obstructive liver diseases and bone disorders, 
starting from whole blood samples was developed. The GrFFF-CL POCT 
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system was able to give quantitative results on blood samples from 
control and patients with low sample volume (0.5 L) and reagent 
consumption, short analysis time (10 minutes), high reproducibility 
and with a linear range of 50–1400 IU L-1. The system can be easily 
applied to on-line prepare plasma from whole blood for other clinical 
biomarkers and for other assay formats, based on immunoassay or 
DNA hybridization. 
In Chapter 4, a miniaturized multiplex biosensor exploiting a 
microfluidic oligonucleotide array and chemiluminescence (CL) 
lensless imaging detection is reported for parvovirus B19 genotyping. 
The portable device consists of a reaction chip, comprising a glass slide 
arrayed with three B19 genotype-specific probes and coupled with a 
polydimethylsiloxane (PDMS) microfluidic layer, and a charge-coupled 
device (CCD) camera modified for lensless CL imaging. Immobilized 
probes were used in DNA hybridization reactions with biotin-labeled 
targets, and then hybrids were measured by means of an avidin-
horseradish peroxidase (HRP) conjugate and CL detection.  
Chapter 5 reported the development of a multiplex chemiluminescent 
biosensor for on-site simultaneous quantification of Aflatoxin B1 and 
type B-Fumonisins in maize samples based on CL-Lateral Flow 
Immunoassay (LFIA), in order to combine the simplicity of the LFIA 
technique with the advantages offered by CL detection. The biosensor 
integrates a multiplex indirect competitive lateral flow immunoassay 
(LFIA) based on enzyme-catalyzed CL detection and a CCD camera, 
employed in a lensless “contact” imaging configuration. The developed 
assay requires a simple extraction of the analytes from maize flour 
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samples followed by their detection with a 30-min assay time. The use 
of CL detection allowed accurate and objective analytes quantification, 
enabling simultaneous detection of type B-Fumonisins and Aflatoxin 
B1 down to 6 g kg-1 and 1.5 g kg-1, respectively, thus fulfilling the 
standard imposed by the legislation of European Union.  
Chapter 6 reports about a different new CL detector, that is back side 
illuminated CMOS used in smartphone cameras that can provide a 
further minizaturization and simplification of the analytical system. 
Nowadays improvements in the sensitivity of the back side illuminated 
CMOS used in new generation smartphone cameras make them 
amenable for detecting CL signals. Moreover, the connectivity and data 
processing offered by smartphones can be exploited to perform 
analyses directly at home with simple procedures. We therefore 
developed a portable analytical device, employing 3D printing 
technology, that transforms a smartphone into a CL detector for 
quantitative analysis based on LFIA and we demonstrated the 
performance of the system by quantitative detection of salivary 
cortisol, which is considered a biomarker of stress, anxiety, and 
depression and thus requires highly sensitive and accurate assays in 
order to detect disease-related variations at nanomolar levels.  
In Chapter 7 an innovative detector for CL measurement based on 
hydrogenated amorphous silicon (a-Si:H) photodiode array was 
proposed as an alternative to conventional bench-top instrumentation. 
In order to state the suitability of a-Si:H photodiodes as ultrasensitive 
detection devices for Lab-on-Chip (LOC) systems, we designed, 
fabricated and characterized a LOC system with integrated 
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photosensors and applied it to two different “model” bioassays. The 
system includes an array of 16 a-Si:H photodiodes deposited on a glass 
substrate, on which a PDMS unit containing 16 wells was applied to 
obtain an integrated microcartridge. A custom portable readout 
electronic board was employed. Firstly, device performances were 
characterized at the photosensor level and at analytical level in terms 
of noise, sensitivity, detectability with different CL and BL systems, 
comparing the analytical performances with reference state-of-the-art 
laboratory instrumentation. Finally, the device functionality was 
successfully tested on two model bioanalytical BL (cell toxicity assay) 
and CL (total antioxidant capacity measurements) assays. This device 
provides efficient photon transfer between the sample-well and the 
photosensors, thus increasing assay sensitivity. In addition, the very 
compact dimensions, favourable for miniaturization, the low-cost and 
the versatility make it a good candidate for developing miniaturised 
biosensors with high detectability and sensitivity. 
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CHAPTER 3 
 
 
Gravitational field-flow  fractionation integrated with 
chemiluminescence detection for a self-standing point-of-care 
compact device in bioanalysis 
 
 
 
 
 
 
 
 
 
 
Reproduced from: “Gravitational field-flow  fractionation integrated with 
chemiluminescence detection for a self-standing point-of-care compact 
device in bioanalysis”  
Sonia Casolari, Barbara Roda, Mara Mirasoli, Martina Zangheri, D. 
Patrono, Pierluigi  Reschiglian, Aldo Roda 
Analyst, 2013, 138, 211–219  
Reproduced by permission of The Royal Society of Chemistry 
http://pubs.rsc.org/en/content/articlepdf/2013/an/c2an36041a 
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3.1 Introduction 
 
The “Point-Of-Care Testing” (POCT) approach, based on the development 
of miniaturized and portable analytical platforms, aims at rapidly 
performing clinical chemistry assays directly where the sample is 
obtained. To meet analytical and diagnostic requirements, a POCT device 
should combine portability, minimum sample pre-treatment, and the 
possibility to perform highly sensitive simultaneous detection of several 
biomarkers (multiplexing) in a short assay time. 
Sample pre-treatment is the most critical point to reach the needed 
specificity and detectability in many bioassays conducted on complex 
biological samples (such as blood, urine, or saliva). Despite this, while 
great research effort has been directed toward the development of 
miniaturized analytical devices and biosensors for diagnostic applications, 
the integration of pre-analytical sample preparation and/or clean-up 
modules still represents the key bottleneck for realizing a totally 
integrated analytical device application [1]. In specialized laboratories, 
blood clinical analyses are commonly carried out on cells and plasma 
components after their separation, generally through a centrifugation step 
that requires a volume of whole blood samples in the range of milliliters. 
Various miniaturized systems have been proposed to prepare cell-free 
plasma, possibly from small volumes of whole blood, such as microfluidic 
systems exploiting cross-flow filtration [2,3], “lab-on-a-disc” systems 
exploiting centrifugal forces [4] and biomimetic microfluidic separation, 
microstructures, magnetophoresis, acoustophoresis and dielectrophoresis 
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[5,6]. However, such systems do not provide total recovery of plasma and 
in most cases the efficiency of separation is not satisfactory. In addition, 
most of the proposed methods present problems of clogging, lead to the 
rupture of blood cells owing to high shear forces and do not allow 
collection of cellular materials for further analysis. 
In this context, the field-flow fractionation (FFF) family of flow-assisted 
separation techniques represents a more versatile and multiplexed 
solution, being able in the same run both to separate plasma from whole 
blood and to further fractionate cellular components by a non-invasive 
process and a simple and easily automatable system setup. In FFF the 
separation is achieved within a capillary empty channel in which a laminar 
flow of the mobile phase sweeps sample components down the channel. 
A field is applied perpendicularly to the parabolic flow to make the 
analytes be driven into different laminar flows due to their differences in 
physical properties such as molar mass/ size, density, and surface 
properties, resulting in different retention times. Thanks to its “soft” 
separation mechanism, FFF has been successfully applied to a wide range 
of bioanalytes, from relatively small biomolecules to living cells in complex 
biological samples, which after separation keep their native characteristics 
such as enzymatic activity, cell integrity and vitality, or quaternary protein 
structure [7,8]. The gravitational FFF (GrFFF) variant, exploiting the Earth 
gravitational field to structure the separation, appears to be particularly 
suited for its implementation in POCT devices, thanks to the simplicity of 
its separative device, amenability to miniaturization, and the potential 
easy on-line integration with specific analytical modules. GrFFF was 
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extensively used as non-invasive cell sorting techniques [9–11], and we 
have recently demonstrated the possibility of increasing its selectivity by 
derivatizing the fractionation device walls with biospecific reagents [12]. 
Herein, we propose to exploit the potentialities of GrFFF towards the 
development of an on-line pre-analytical simple module of a POCT device, 
able to fractionate sample components, thus providing a selectively 
enriched fraction for the analysis with an increase of the overall analytical 
output. After fractionation, sample components can be on-line transferred 
to different analytical modules where analytes are quantified. 
GrFFF was coupled with chemiluminescence (CL) detection, which has 
been shown to be particularly suited for its implementation in 
miniaturized POCT devices, since it offers high detectability also in small 
volumes and it avoids the need for photoexcitation and wavelength 
selection systems [13,14]. We have recently demonstrated the potential 
analytical applications of GrFFF coupled with CL detection for the 
development of rapid and ultrasensitive immunoassays [15,16]. 
As a first approach, we present a novel GrFFF-CL integrated device able to 
prepare whole blood samples for the automatic on-line measurement of 
the activity in plasma of alkaline phosphatase (ALP, EC 3.1.3.1), an enzyme 
produced primarily in the liver and intestine. Measurements of ALP 
activity in plasma are used as a first level screening test for obstructive 
liver diseases and bone disorders, elevated levels usually prompting 
further testing to complete the diagnosis [17]. Most frequently, 
spectrophotometric techniques are employed, exploiting the ability of the 
enzyme to catalyze the conversion of p-nitrophenyl phosphate (PNPP) to 
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p-nitrophenol (405 nm maximum absorbance). Several kits (such as those 
produced by TC Diagnostic, Anaheim CA; AbCam Inc. Cambridge, MA; 
QuantiChrom, BioAssays Systems, Hayward, CA) and automatic devices 
(such as Cobas® by Roche Diagnostics Corporation, Indianapolis, IN) also 
for POCT applications (such as SpotChem EZ by A. Menarini Diagnostics, 
Firenze, Italy) based on colorimetric detection are commercially available 
for ALP activity measurement in serum. Nevertheless, such methods are 
limited by interferences from absorbing molecules in plasma (e.g., 
bilirubin, haemoglobin). Other sensitive methods, amenable to 
miniaturization, were described, such as CL detection [18], or 
electrochemical detection, although this system was not tested on human 
serum or plasma samples [19]. However, most of these systems are not 
applicable to whole blood samples and they require preliminary 
separation of serum/plasma from whole blood. A method based on 
voltammetric determination was described to measure ALP activity in 
whole human blood, which however provided a limit of detection and a 
linear range not adequate for diagnostic applications [20]. In the proposed 
GrFFF-CL integrated device, after the injection of a small volume of 
heparin-treated whole blood, plasma is separated from cells which elute 
at different retention times and is then addressed by means of a 
-analytical module, where the enzyme 
activity is measured by means of an on-line flow-through luminometer. To 
obtain a compact GrFFF device, amenable to miniaturization and easily 
integrated in a microfluidic system for POCT applications, the channel 
geometry was modified with respect to the conventional linear 
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rectangular shape and a more compact GrFFF device containing the 
separative channel was used. The method has been validated by 
comparing the results obtained from whole blood samples with those 
obtained by analyzing serum by a conventional clinical chemistry test 
routinely used in hospital laboratories. 
3.2 Materials and methods 
3.2.1 Reagents 
 
The CL substrate Lumi-Phos® Plus, containing Lumigen PPD (4-methoxy-4-
(3-phosphatephenyl)spiro[1,2-dioxetane-3,20-adamantane] disodium salt 
and a patented enhancer in 2-amino-2- methyl-1-propanol buffer (pH 9.6), 
was purchased from Lumigen Inc. (Southfield, MI, USA). Being Lumigen 
PPD photosensitive, it was protected from light throughout the analysis. 
Sodium chloride (NaCl) was acquired from Sigma Aldrich Co. (St. Louis, 
MO, USA) and the lyophilized calibrator for Automated Systems (C.f.a.s. 
10759350), from Roche (Basel, CH, Switzerland), was kindly supplied by 
the Clinical Chemistry Central Laboratory of the S.Orsola-Malpighi hospital 
(Bologna, Italy). Saline solution (9 g L-1 NaCl in ultrapure MilliQ water) was 
used for samples and calibrators dilution and as a FFF mobile phase. 
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3.2.2 Samples 
 
Calibrator: 
A stock ALP solution having a certified concentration (460 IU L-1; IU = 
International Unit for enzymatic activity) was obtained by reconstitution 
of the lyophilized C.f.a.s. with 3 mL of ultrapure MilliQ water. The stock 
ALP solution (that is stable for 8 h at room temperature, 2 days at 2–8 °C 
and one month at -20 °C) was serially diluted with saline solution to 
provide ALP standard solutions, which was used to obtain calibration 
curves. Dilutions of the stock ALP solution were also prepared at 1.5, 4.0, 
and 6.0 IU L-1 ALP activity and used as quality control samples. 
 
Control plasma and whole blood: 
Five different control plasma samples having ALP enzymatic activity 
ranging between 0.625 and 7.000 IU L-1  were prepared by serially diluting 
with saline solution a reference plasma (BIO-RAD, Hercules, CA) having a 
70 IU L-1  certified ALP activity and they were used to check the calibration 
curve. Control plasma was kindly supplied by the Clinical Chemistry 
Central Laboratory of the S.Orsola-Malpighi hospital (Bologna, Italy). Fresh 
human blood samples were collected in heparintreated tubes from 15 
healthy donors and 10 patients affected by cholestasis. Prior to inclusion 
in the study, each subject gave his/her written informed consent. 
For each analysis, 0.5 L of whole blood (or plasma isolated after 
centrifugation for comparison purposes) were injected upon simply a 
1:100 (v/v) dilution with saline solution. For each sample, ALP activity was 
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calculated by interpolation of the CL signal on the calibration curve and 
corrected for the sample dilution factor. In addition, for each blood 
sample, the value of ALP activity in plasma was calculated by considering 
the dilution factor of plasma in whole blood (blood is composed of 55% 
plasma and 45% cellular components) [21,22] in order to allow 
comparison of the results with those obtained in plasma with the 
reference method. Results obtained by the developed method on control 
samples and real samples were compared with those obtained by the 
optimized method Cobas® routinely used in the Clinical Chemistry Central 
Laboratory of the S.Orsola-Malpighi hospital (Bologna, Italy). This method, 
based on the colorimetric measurement of ALP activity, is applied to 
serum samples and it provides a dynamic range of the measurement in 
the interval 5– 2000 IU L-1, with a run-to-run CV of <0.5%, a day-to-day CV 
of <2% and a recovery of ±5% of the initial value. Alkaline phosphatase 
values lower than 270 IU L-1 for men and lower than 240 IU L-1 for women 
measured at 37 °C were considered normal values for physiological 
conditions. 
3.2.3 GrFFF-CL POCT system 
 
The GrFFF-CL system was composed of two main integrated modules: the 
GrFFF device and the CL analyzer, which were online connected as 
described in the following paragraphs and depicted in Fig. 1. 
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Figure 1: Scheme of the GrFFF-CL system. The GrFFF module is composed 
of a system for carrier delivery, a tube for sample injection, the GrFFF 
device (comprising the Sshaped channel and plastic walls), the UV/vis 
detector, and a splitting valve to drive selected fractions to the integrated 
CL module (comprising a system for reagents delivery and a CL detector). 
 
GRFFF MODULE. The GrFFF fractionation module (Fig. 1) was based on a 
new GrFFF channel design with respect to the conventional rectangular 
geometry. The GrFFF channel, cut from a Mylar spacer, had a curvilinear 
shape with an S geometry characterized by two curvilinear parts of 3.9 cm 
with a radius of curvature of 1.25 cm. The channel presented conventional 
dimensions of 30.0 cm in length (tip-to-tip), 0.018 cm in thickness and 1.0 
cm in breadth and it was sandwiched between polycarbonate (PC) and 
polyvinyl chloride (PVC) walls, both from Plasticenter (Bologna, Italy), thus 
making the GrFFF device suitable for blood fractionation. The S geometry 
allowed for obtaining a GrFFF device with a 55% reduction in overall size. 
In its current configuration, the carrier flow was delivered by a peristaltic 
pump (Miniplus Gilson Plus), while the GrFFF outlet was fed to the CL-
analysis module described below. Samples and standards (injection 
volume 50 L) were directly injected into the channel via a PEEK inlet tube 
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(L = 5 cm, i.d. = 0.750 mm, o.d. = 1/16 in) by means of a Hamilton syringe. 
They were manually shaken for some seconds before the injection which 
was performed at a flow rate of 0.2 mL min-1 for 15 s. Then the flow was 
stopped for 2 min to allow sample relaxation. After the stop-flow time, the 
flow was restarted at a flow rate of 1.0 mL min-1  for sample elution. 
During the elution, whole blood components were fractionated: plasma 
was not retained and eluted in the void peak, while cellular components 
eluted later following the GrFFF fractionation mechanism. The elution 
process was registered by means of an on-line UV6000 LP, diode array 
UV/vis detector (Thermo- Quest, Austin, TX), operating at 280 nm and 600 
nm. 
 
CL-ANALYSIS MODULE. By means of a splitting L-valve, a fraction of the 
void peak, containing plasma components of the sample, was on-line sent 
from the channel outlet to the CL analysis module, where ALP activity was 
quantified by postcolumn reaction, as described below. The CL analysis 
module was constituted by an on-line mixer to blend the eluted fraction 
with the CL enzyme–substrate and by a flow-through CL detector (FB12 
luminometer, Berthold Detection Systems, GmbH, Pforzheim, Germany) 
equipped with a flow-cell specifically modified, as previously described, to 
perform flow measurements [15]. This cell (186 L) was created by 
employing transparent Teflon tubing (L = 23 cm, i.d. = 1 mm, 8.107 L cm-
1) bound on itself and placed in a glass test tube into the luminometer. In a 
perspective, the L-valve can be used to switch different fractions of the 
same samples to different analytical modules eventually on-line 
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connected to the GrFFF device resulting in a multiplexed POCT system. 
Alkaline phosphatase activity was measured by employing the CL 
substrate Lumi-Phos-Plus® diluted 1 : 9 (v/v) with saline solution, warmed 
to 37 °C and delivered by the peristaltic pump (Gilson) at a flow rate of 1.8 
mL min-1  for 10 s. The proportion between the sample and the substrate 
into the flow-through CL analyzer was fixed to 1 : 1.8 (v/v), as determined 
by flow rates of the mobile phase and the CL substrate. These 
experimental conditions were adopted to minimize the costs of a single 
run ensuring, at the same time, that the initial reaction speed depends 
only on enzyme activity. The CL mixture was stopped into the flow-
through CL detector cell and the signal was acquired for 3 min; then, the 
flow was restored to wash out the sample and to make the system ready 
for further analysis. The value of enzyme activity was calculated from the 
slope of the CL kinetic curve obtained. After injection of 10 blood samples, 
the entire analytical system was cleaned by flushing ultrapure MilliQ water 
at a flow rate of 1 mL min-1 for 30 minutes, then a cleaning solution (30% 
v/v ethanol and 0.5% w/v sodium dodecyl sulphate (SDS) in ultrapure 
MilliQ water) was flushed at 0.5 mL min-1  for 20 minutes. The system was 
finally rinsed with ultrapure MilliQ water at 1.5 mL min-1  for 30 minutes, 
before restoring the mobile phase. 
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3.3 Results and discussion 
3.3.1 Principle of the assay/preliminary assays 
 
In this work, an on-line GrFFF-CL system was designed and optimized for 
its applicability in bioanalysis in a POCT setting, by integrating a GrFFF 
channel in an innovative format with a fluidic CL detection module. Blood 
ALP activity was used as a model analyte. Preliminary work was conducted 
to investigate the possibility of a direct measurement of ALP activity in 
whole blood, by addition of the CL substrate to highly diluted (1:100 to 
1:500 v/v) blood samples, exploiting high CL detectability. However, poor 
reproducibility and sensitivity were obtained (data not shown), thus 
confirming the need of a simple sample pre-treatment in order to obtain a 
robust method suitable for diagnostic applications. In view of a POCT 
application, the GrFFF-CL system was developed by employing an original 
curvilinear geometry for the GrFFF channel, in order to obtain a compact 
device. The influence of the new geometry on the fractionation 
performance was preliminary evaluated on blood samples by employing 
CL imaging accomplished by placing the GrFFF transparent channel in a 
dark box and by acquiring, through a highly sensitive, back-illuminated, 
double Peltier-cooled CCD camera, the CL emission of fractionated 
analytes at fixed time intervals during the elution, as previously described 
[23]. No significant difference in the fractionation efficiency was observed 
with respect to a conventional rectangular GrFFF channel, both in terms of 
resolution and recovery. 
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Employing such an original channel design, the fractionation method was 
optimized as described below in order to obtain a quantitative method 
with high sensitivity, linear range and reproducibility for the analysis of 
real samples. The developed procedure can be summarized as follows: a 
small volume (0.5 L) of whole blood diluted 1 : 100 (v/v) with saline 
solution was injected in the GrFFF system for separation of plasma from 
cells, which elute at different times. At the exit of the GrFFF channel, a 
fraction of plasma was split to the analytical module, where ALP activity 
could be measured on-line upon mixing with the dioxyethane-based CL 
substrate. For method optimization purposes, the UV/vis detector was on-
line inserted between the channel outlet and the CL analyzer, however, 
thanks to the high reproducibility of the fractionation process, the UV-vis 
detector was eliminated in the final set-up of the GrFFF-CL system.  
3.3.2 Method optimization 
 
FRACTION SELECTION. When whole blood is injected into a GrFFF channel, 
plasma components are not retained by the system and are thus eluted in 
a single peak corresponding to the void volume, while blood cells are 
subjected to retention mechanisms and are thus eluted later (and 
fractionated in cell populations). As a consequence, plasma separation is 
obtained after GrFFF run, without the need of a centrifuging step and with 
low shear stress, thus without cell lysis. At the exit of the GrFFF channel, 
the plasma fraction was split to the CL detection analytical module, while 
cellular components, which were not of interest in the present work, were 
separately collected. A representative GrFFF profile obtained upon 
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injecting whole blood is reported in Fig. 2a, panel I. Since, the whole 
volume of the void peak was much higher (1.5 mL) than the plasma 
volume necessary to perform the CL measurement of ALP activity, only a 
fraction of the void peak was split to the analytical module to reduce CL 
substrate consumption and measurement times. Even if it is expected that 
molecules eluted within the void peak are not differently distributed along 
the peak, since they are not affected by the external field during 
separation, preliminary experiments were performed aimed at confirming 
that the distribution of ALP was homogeneous in the void peak (thus no 
artefact was introduced by analyzing only a fraction of it) and at 
determining which fraction of the void peak would provide the highest 
assay sensitivity and reproducibility, with reduced reagent consumption 
and assay time. For this purpose, after injecting 50 L of diluted whole 
blood, four 250 L fractions of eluting plasma (F1–F4, 15 s collection time 
for each fraction, Fig. 2a, panel II) were separately addressed to the CL 
analysis module, where the kinetics of CL emission was monitored for 3 
min upon mixing for 15 s with the CL substrate, following the procedure 
described in Section 2.3.2. For each fraction, the area under the curve 
measured at l =280 nm (indicating whole protein content, mainly 
represented by human serum albumin and other plasma proteins) and the 
slope of the CL emission profile (indicating ALP activity) were correlated. 
The graph (Fig. 2b) shows a good linear relationship (r = 0.99) 
demonstrating a uniform distribution of ALP within the void peak and 
confirming that any of the fractions collected within the void peak could 
be used for evaluating ALP activity in the blood sample. Fraction 2 of the 
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void peak, corresponding to the peak maximum and therefore to the 
highest amount of plasma components, was employed in subsequent 
experiments to reach higher assay detectability. The optimal splitting time 
for addressing the central fraction of the void peak towards the analytical 
module was assessed to be 10 s, providing high assay reproducibility, as 
shown in Fig. 3, reporting the results of six repeated GrFFF runs and 
showing that void peaks of different fractograms and CL emission profile 
time are completely superimposable. It must be noted that a shorter 6 s 
splitting time provided high CL signals for ALP activity measurements as 
well, thus potentially low detection limits for ALP activity could also be 
reached when employing short sampling times. However, low 
reproducibility was obtained under such conditions in this work, where 
the instrumental set-up employed, in a prototype level of development, 
was based on a manual splitting operation. Future automation of the 
splitting system will most probably enable significant reduction of 
collection time, thus reagent consumption. 
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Figure 2: (a) GrFFF fractionation of whole blood (panel I): 50 mL of diluted 
(1/100 v/v in the mobile phase) whole blood, mobile phase ¼ NaCl 9 g L_1, 
elution flow rate = 1 mL min_1, relaxation time = 2 min and fractographic 
profile registered at 280 nm. The first band represents the void peak 
corresponding to unretained analytes (serum components); the second 
band corresponds to retained blood cells. Void peak partitioned in 15 s 
collected fractions (panel II): F1–F4 fractions of the void (serum) peak used 
for the CL assay. (b) ALP activity (slope of the CL emission profile) for F1–
F4 collected fractions vs. area under the curve of the fractographic profile 
measured at l =280 nm (reflecting the whole protein content in each 
fraction). The F2 fraction which has the higher band area also shows the 
higher CL intensity. 
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Figure 3: (a) Superimposition of void peaks of the fractographic profiles for 
six subsequent blood injections in the GrFFF system. The central portion of 
the void peak (evidenced in grey in panel a) corresponding to a 10 s 
splitting time was selected as a serum collection time for determination of 
ALP. (b) Results for chemiluminescence ALP activity measurements on the 
selected fraction for the six subsequent injections. 
 
EXPERIMENTAL PARAMETERS OPTIMIZATION. Saline solution (9 g L-1  NaCl) 
was employed as a mobile phase and to dilute all samples to maintain 
physiological conditions during fractionation, thus preserving enzyme 
activity and cell integrity. As enzyme activity is affected by the 
temperature, to fulfil international standards for enzymatic 
measurements in clinical chemistry, the analytical CL module was 
thermostatted at 37 °C, obviously complicating the instrumental design in 
a perspective of a POCT application. Explorative tests, performed also at 
25 °C, showed that, although a significantly higher signal was obtained for 
the blank (Fig. 4a), a linear calibration curve was obtained (Y = 86X -15, r = 
0.99), indicating the possibility of giving a conversion factor for analysis to 
be performed at 25 °C. Optimization experiments were performed to 
minimize the CL substrate consumption while maintaining an excess 
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substrate to obtain an analytical signal only dependent on enzyme activity. 
Dilution factors for the Lumi-Phos- Plus substrate with saline solution 
ranging from 1 : 2 to 1 : 9 (v/v) were tested, the optimal one being 
assessed to be 1 : 9 (v/v). The memory effect between subsequent runs 
was also evaluated by measuring the blank signals that, while being very 
low and constant when a blood sample was injected into a new GrFFF 
channel, significantly increased after ten repeated blood injections. This 
memory effect, probably due to the weak adsorption of ALP molecules on 
the channel walls and their release during the subsequent runs, was 
eliminated by adopting a short channel cleaning procedure, as described 
in Section 2.3.2. The procedure was able to eliminate any ALP molecule 
adsorbed on the channel wall and the resulting memory effect (Fig. 4b). It 
must, however, be noted that, thanks to the low cost of the GrFFF device, 
the separative device is suitable for a disposable usage, thus eliminating 
the memory effect problem. 
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Figure 4: (a) CL signals measured at 25 °C and at 37°C when the assay was 
conducted in the absence of the blood sample (blank signal) by analyzing 
50 L of the mobile phase under the GrFFF-CL conditions. (b) CL blank 
signals measured employing a newly prepared GrFFF channel, after 10 
subsequent blood analysis, and using the same channel restored by the 
cleaning procedure described in Section 2.3.2. 
 
3.3.3 Quantitative analysis 
 
CALIBRATION RESULT. A calibration curve was obtained by employing ALP 
standard solutions, displaying a linear range from 0.5 to 14 IU L-1, which 
corresponds to 50–1400 IU L-1  when considering the 1 : 100 (v/v) dilution 
factor employed for injected samples. The equation Y = 54.0 (±0.2)X + 8 
(±2) was obtained when repeating the calibration 15 times (r = 0.99). It is 
to be underlined that physiological reference values of enzymatic activity 
of ALP of the adult healthy subject range from 45 to 270 IU L-1, while 
higher values (generally up to 1400–2000 IU L-1) are encountered in 
pathologic situations, such as obstructive liver diseases and bone 
disorders. The limit of detection (LOD), calculated as the ALP activity 
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corresponding to the signal of the blank plus three standard deviations, 
was 28 IU L-1. The dynamic range of the developed method is thus suitable 
for the analysis of blood samples presenting normal, abnormally elevated, 
or abnormally low ALP activity levels. Samples characterized by ALP levels 
lower than the LOD method may be re-analyzed upon a 1 : 10 (v/v) 
dilution, since we have excluded the presence of matrix effects at this 
sample dilution (Section 3.3.3). 
 
VALIDATION OF THE CALIBRATION PROCEDURE. The analytical 
performances of the quantitative method were evaluated by employing 
two types of samples: quality control samples (prepared by serially 
diluting the stock ALP solution, having a 460 IU L-1  certified ALP activity) 
and control plasma samples containing also matrix elements (prepared by 
serially diluting a reference plasma sample, having a 70 IU L-1  certified ALP 
activity). The reproducibility of the method was assessed by analyzing 
quality control samples at 1.5, 4.0 and 6.0 IU L-1  ALP activity 
(corresponding to 270, 730, and 1090 IU L-1  in undiluted plasma, 
calculated as detailed in Section 2.2). Results are reported in Table 1. The 
intra-assay CVs across the entire range were below 2% (n = 15), while 
inter-assay CVs, obtained in five different days, were below 4%. Accuracy 
was determined by repeatedly analyzing control plasma samples, having a 
certified ALP activity value in the range (0.65–7.00) IU L-1  corresponding to 
final ALP concentrations in the range (120–1270) IU L-1. Results, reported 
in Table 2, show recovery values in the range from 110 to 93%, thus 
confirming the accuracy of an ALP quantification procedure. 
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The analysis of pathological samples displaying ALP activities higher than 
1400 IU L-1  can be performed by further diluting the sample prior to 
analysis. 
As stated above, automatization of the system may allow a higher control 
of the flow and splitting times, with a potential reduction of the sampling 
time and a consequent increase in the dynamic range of the method. 
 
 
Table 1: Reproducibility of the method: measured ALP activity of quality 
control samples compared with real values obtained by the reference 
Cobas® method 
 
55 
 
 
Table 2:  Accuracy of the method: repeated analysis of control samples 
having certified ALP activity (real value) 
 
MATRIX EFFECT EVALUATION. Calibration curves obtained either with 
external standard (employing ALP standard solutions) or with standard 
addition procedures (employing a reference blood sample of 61 IU L-1  ALP 
activity, as determined by the reference Cobas- method) were compared, 
to verify the absence of matrix interferences. Each measurement was 
performed in triplicate. A dilution of 1/10 (v/v) for injected samples was 
chosen to stress the study of matrix components. Fig. 5a shows a 
representative calibration curve obtained with the external standard 
procedure, in the range 3–32 IU L-1  (corresponding to 550 to 5820 IU L-1  
concentrations in an undiluted plasma sample calculated as detailed in 
Section 2.2). 
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A linear relationship was observed between the ALP activity and the CL 
signal (r =0.99). Finally, when the ALP activity in the reference blood 
sample (diluted 1 : 10 v/v with saline solution) was calculated by 
interpolation on the calibration curve, a value of 60 ± 6 IU L-1  of ALP 
activity (calculated as activity in undiluted plasma) was obtained, which 
was not significantly different from the value obtained by the reference 
method (p > 0.01). The calibration curve obtained by employing the 
standard addition (Fig. 5b) was produced by addition of ALP standards in 
the range 6–23 IU L-1  (corresponding to 1090–4180 IU L-1  in undiluted 
plasma) to aliquots of the reference blood sample, previously diluted 1 : 
10 v/v with saline solution. A linear relationship was observed between 
the ALP activity and the analytical CL signal (r = 0.99) and a value of 58- 5.0 
IU L-1 of ALP activity was obtained for the blood sample, which is not 
significantly different from the reference value (p = 0.05). In addition, no 
significant difference was observed between the slope of calibration 
curves obtained by employing the two methods (p > 0.05), thus 
demonstrating the absence of matrix effects. 
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Figure 5: (a) Calibration curve for external standard obtained by analyzing 
ALP standard solutions in the range 3–32 IU L-1; (b) calibration curve for 
standard additions obtained by analyzing aliquots of the blood sample 
fortified with ALP standards in the range 6–23 IU L-1. 
 
3.3.4 Real samples analysis 
 
Fresh human blood samples were drawn from healthy donors (n = 15) and 
patients affected by cholestasis (n = 10) in heparintreated tubes. The 
samples had ALP activity in plasma values ranging from 500 to 1200 IU L-1, 
as determined by the reference Cobas- method. For each sample, 0.5 L 
of whole blood diluted 1 : 100 (v/v) was analyzed in the GrFFF system in 
five replicate analyses. Results (calculated as plasma ALP activity) were 
compared with those obtained by the reference Cobas® method and a 
good agreement was observed. Moreover, in order to test the robustness 
of the method, different dilutions of blood samples and plasma obtained 
from the same sample were analyzed with the GrFFF-CL system. 
Representative results for a normal sample and a pathological sample, 
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reported in Table 3, show that recovery values ranged between 90 and 
110%, thus confirming the method accuracy. 
 
 
Table 3: GrFFF-POCT results for normal and pathological samples 
 
3.4 Conclusion 
 
The results show the potentialities for the quantitative detection of 
specific analytes in plasma samples after their separation from cellular 
components employing a simple and compact GrFFF system on-line 
integrated with a flow-through CL analyzer. Quantitative detection of ALP 
activity was obtained with high analytical performances comparable to 
conventional diagnostic systems, with the advantages of lower sample and 
reagent consumption, shorter analysis time and simple instrumentation 
acting directly on the blood sample. The developed method was shown 
able to highly efficiently separate plasma from a very small volume (0.5 
59 
 
L) of whole blood, in short analysis time (10 minutes) and high 
reproducibility (run-to-run CD <2%, day-today CV <4%). Such a low sample 
volume makes the assay compatible with a finger stick blood collection 
procedure, suitable for a POCT environment. GrFFF thus represents a 
convenient tool to assist bioanalytical methods acting on plasma or serum, 
since it easily online isolates plasma components without the need of 
centrifugation steps. The same approach can be extended to any bioassay 
terminating with a CL reaction, including also immunoassay and gene 
probe assays performed in microfluidic platforms and employing CL labels. 
In principle, with the same injected sample, different analytes could be 
detected in plasma by splitting different plasma fractions to different 
specific analytical modules. In addition, the fractionation method used in 
this work allows preservation of all the native properties of analytes and 
cells that could be further analyzed with increased analytical information. 
Finally, due to the simplicity of the proposed system, many detection 
modules can be simultaneously connected to the GrFFF device, realizing 
multiplexed analysis. In the present study, an innovative curvilinear 
geometry for the GrFFF channel was employed to obtain a compact 
device, while keeping the same fractionation performance obtained by the 
GrFFF device containing traditional rectangular channels. In the future, 
further miniaturization may be accomplished by building a microchannel 
on a support that also integrates microstructures for sample and mobile 
phase delivery. The use of an array of GrFFF channels will also be 
considered to increase enrichment productivity and to allow the 
60 
 
development of multiplexed systems based on the same separative 
principle  
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CHAPTER 4 
 
 
Portable chemiluminescence multiplex biosensor for 
quantitative detection of three B19 DNA genotypes 
 
 
 
 
 
 
 
 
 
 
 
Reproduced from: “Portable chemiluminescence multiplex biosensor for 
quantitative detection of three B19 DNA genotypes” 
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Giorgio Gallinella, Aldo Roda 
Analytical and Bioanalytical Chemistry, 2013, 405:1139–1143 
Reproduced by permission of Springer (License number 3580690366855) 
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4.1 Introduction 
 
The parvovirus B19 is a very common virus in the population and it is 
implicated in a wide spectrum of pathological conditions such as erythema 
infectiosum, arthropathy, hemolytic anemia and aplastic transitional crisis. 
The infection is also associated with rare clinical manifestations such as 
myocarditis, hepatitis, encephalitis, chronic fatigue syndrome and some 
autoimmune diseases [1]. In pregnant women, the infection can lead to 
the development of non-immune fetal hydrops, miscarriage and fetal 
death [2]. The availability of portable and rapid diagnostic systems would 
allow an early diagnosis of viral infection by means of systems "Point-of-
Care Testing" that might be useful start promptly the treatment with 
consequent reduction of adverse fetal outcomes. Moreover since B19V 
can be found in three different genotypes (G1,G2, and G3) which 
epidemiology still needs further studies, virus genotyping represents an 
interesting issue for monitoring B19 epidemiology. Biospecific binding 
assays exploiting chemiluminescence (CL) detection represent one of the 
most promising approaches towards miniaturized multiplex assays 
characterized by high detectability and rapidity [3]. Recently, a versatile 
and portable bioanalytical device relying on CL lensless charge-coupled 
device (CCD)-based imaging was developed to perform hybrid multiplexed 
assays, enabling detection of enzymes, antigens, and nucleic acids [4]. 
Digoxigenin-labeled amplified products from parvovirus B19 DNA, selected 
as a model nucleic acid analyte, were detected by hybridization with an 
immobilized capture probe and hybrids detection employing a horseradish 
peroxidase (HRP)-conjugate antibody and a CL substrate. However, the 
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limit of detection (LOD) of the assay was 50 nmol L-1, thus not adequate 
for diagnostic applications. Herein, it is reported an optimized assay 
displaying improved detectability and the ability to distinguish between 
three different B19 virus genotypes [5]. The reaction chip was designed 
employing capillary forces instead of pumping devices to drive the flows of 
samples and reagents in order to obtain a minimally instrumented 
portable device. 
The developed miniaturized multiplex biosensor is based on 
oligonucleotide array and chemiluminescence (CL) lensless imaging 
detection for parvovirus B19 detection and genotyping. The portable 
device consists of a reaction chip that is composed by:  
- a glass slide chemically activated and arrayed with three B19 
genotype-specific probes for the capture of DNA. The slide has to be 
integrated with fluidic elements (reservoirs and microchannels) in 
polydimethylsiloxane (PDMS) to deliver samples and reagents (Fig. 
1a).  
- A thermoelectrically cooled CCD camera employed for detection 
and spatial localization of the CL emission, exploiting the “position 
encoding” approach, in which the spatial localization of the 
analytical signal provided analyte identification (Fig. 1b). 
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Figure 1: a) Layout of the disposable reaction chip combining a glass slide 
with arrayed B19 genotype-specific oligonucleotide capture probes (3×3 
array) and a PDMS microfluidic layer. b) A thermoelectrically cooled CCD 
camera employed in “contact” imaging approach. Measurement area 
corresponds to the reaction chip area that is positioned on the fiberoptic 
taper surface. 
 
Coupling between the functionalized glass support and the CCD camera 
was obtained by “contact” imaging (i.e., without employing lenses or 
similar optics elements) to reduce the complexity and size of the device 
and to improve CL signal detectability [6]. Hybrids were then detected by 
means of an avidin-HRP conjugate, upon addition of a CL HRP substrate. At 
first, artificial oligonucleotide targets, perfectly matching in sequence and 
length the corresponding probe sequence, were used for method 
development. Subsequently, biotin labeled amplified products obtained 
from a B19 control plasmid and from reference clinical samples were 
assayed to assess diagnostic applicability. 
 
66 
 
4.2 Materials and methods 
4.2.1 Oligonucleotide array biosensor  
 
The reaction chip for B19 genotyping was obtained by combining a 
microscope borosilicate glass slide (26× 76 mm2, Thermo Fisher Scientific, 
Waltham, MA) with a polydimethylsiloxane (PDMS) microfluidic module. 
The disposable microfluidic module consisted of three channels (40 mm 
length, 1 mm width, and 0.1 mm height) with 100-μL inlet reservoirs, 
while the common outlet reservoir was a 4-cm2 adsorbent cellulose pad 
(Whatman CF7, Whatman plc, Maidstone, UK). The  bioprobe 
immobilization was performed by activating the slide glass surface with 
polyetheramine (JEFFAMINE® ED-600, generously provided by Huntsman 
Corporation, Everberg, Belgium) according to a reported procedure [7]. 
The genotype specific oligoprobes were then spotted (0.2 pmol/spot) in 
triplicate in an array of nine (3×3) spots, each one not exceeding 1 mm in 
diameter and 5 mm spacing.  
4.2.2 B19 probes and artificial targets  
 
On the basis of genomic reference sequences available in the National 
Center for Biotechnology Information nucleotide data base B19 probes 
and targets were designed. The 25-mer B19 probes were amino-modified 
(NH2) at 5′-end using a spacer arm of 12 carbon atoms. The 
complementary 25-mer B19 artificial targets were biotin labeled at the 5′-
end. A biotinlabeled 25-mer B19-negative control target was also designed 
basing on a previously published synthetic sequence [8].  
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4.2.3 B19 amplified plasmid DNA and clinical samples  
 
Using a multiplex PCR assay enabling the simultaneous amplification of 
the three B19 genotypes, biotin-labeled amplified products (145 base 
pairs) were obtained. A biotin modified forward primer and two different 
reverse primers were used for amplification, as reported in a published 
procedure [9]. Amplified products were prepared either from a B19 
genotype 1 plasmid DNA or from ten purified serum samples (five positive 
and five negative), which were previously assayed with a reference 
PCRELISA method [10]. To enable construction of a calibration curve, 
amplified products obtained from the plasmid DNA were purified using 
the Wizard® PCR Clean-Up System (Promega Corporation, Indianapolis, IN) 
and the concentration was fluorimetrically estimated (QuantiFluor™ ds 
DNA System, Promega Corporation). The products were denatured by 
incubation at 95 °C for 5 min, and then iced before hybridization 
procedure. 
4.2.4 Assay procedure 
 
For hybridization procedure phosphate-buffered saline (PBS) at pH 7.6, 
sodium dodecyl sulfate (SDS), 0.05 M borate buffer at pH 9.6, and saline 
sodium citrate (SSC) buffer were used. 
The analysis procedure steps are the following (Fig. 2): 
- 50 μL of hybridization buffer (5× SSC, 0.1 % SDS) containing the 
artificial targets at different concentrations (from 1.6×10−2 to 10 
nmolL−1), or the denatured and purified product of amplification 
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from plasmid DNA (diluted at concentrations from 8×10−2 to 50 
nmolL−1), or 10 μL of the denatured product of amplification from a 
clinical sample, are dispensed in the inlet reservoir and let flowing 
through the channels; 
- washing step is performed with 100 μL of 2× SSC containing 0.1 % 
SDS to remove nonspecific DNA–DNA hybrids; 
- 50 μL of HRP-labeled avidin (from Sigma-Aldrich, St. Louis,MO; 50 
μgL−1 in PBS containing 0.1%(w/v) BSA) is added in each cannel; 
- another washing step is performed with 100 μL of PBS 
- 20 μL of SuperSignal ELISA Femto (Thermo Fisher Scientific, 
Waltham, MA) are dispensed in the inlet reservoir and then the 
reaction chip is positioned directly on the taper surface of the CCD-
based device according to the reported procedure; 
- signal is imaged with 30 s acquisition time. 
 
Samples and reagents dispensed in the inlet reservoir flore through the 
channels at a 15- to 20-μLmin−1 flow rate, each assay step requiring 2–3 to 
5–7 min depending on the dispensed volume. Moreover after each step it 
is necessary to change the adsorbent pad.  
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Figure 2: Scheme of the assay procedure 
 
 
4.2.5 Data analysis  
 
Quantitative analysis of CL images was performed using the WinLight 
software v. 1.2 (Berthold Technologies GmbH & Co KG, Bad Wildbad, 
Germany). The mean photon emission measured in the area 
corresponding to probe spots was corrected by subtracting the CL 
substrate background signal that was measured in the absence of target 
analyte and expressed in relative light units. Calibration curves were 
generated by plotting the net value of CL signal was plotted the target 
concentration. The LOD was calculated as the background signal +3 
standard deviations. The same value was selected as cut-off of the assay 
to evaluate the clinical samples.  
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4.3 Results and discussion 
4.3.1 Reaction chip optimization 
 
The immobilization procedure of B19-specific oligoprobes was optimized 
in order to improve the detectability of the assay taking into account the 
previously reported studies [11]. 
The optimization of the concentration of the immobilizer capture probes 
was performed by  spotting different amounts (0.04, 0.2, and 1 pmol) of 
each genotype specific probe along a channel, then performing 
hybridization procedures with the corresponding target (10 nmolL−1) and it 
was found that the highest CL signal was observed for 0.2 pmol for all 
genotypes. 
An higher amount of capture probes provide a decrease in the CL signals 
that might be due to  steric hindrance. Infact in this condition capture 
probes are closely packed together in the spot and therefore less exposed 
to target hybridization [12]. Indeed the optimal surface printing density 
for oligonucleotide arrays [13] is approximately 105 molecules μm−2, that 
corresepond to 0.2 pmol/spot. 
4.3.2 Calibration curves 
 
The calibration curves were generated for each B19 genotype by using 
standard complementary biotin-labeled artificial targets ranging from 
1.6×10−2 to 10 nmol L−1 and are reported in Fig.3. 
For all genotypes the dynamic range of the assay estende from 0.1 to 10 
nmolL−1 and the LOD was 80 pmolL−1 that is lower when compared with  
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that obtained performing a conventional PCR ELISA technique (100 
pmolL−1) using the same reagents. This improvement can be due to the 
optimization of surface functionalization strategy, biospecific capture 
probes design and assay experimental conditions. It was finally ibserved 
that the calibration curve obtained for genotype 3 presents a different 
slope than those obtained for the other genotypes. Maybe this effect is 
caused by the different percentage content of GC couples in hybrids, 
which is 56 % for genotypes 1 and 2, while it is 52 % for genotype 3. 
 
 
Figure 3: CL calibration curves obtained by DNA–DNA hybridization 
reactions between fully complementary B19 capture probe and artificial 
oligonucleotide targets (left) and CL images (right). The coefficient of 
determination (R2) is 0.99 for genotype 1 and 0.98 for genotypes 2 and 3. 
CL data represent the mean values±SD of three separate experiments. RLU 
relative light unit.  
 
4.3.3 Assay specificity 
 
The specificity of the assay was evacuate by analyzing B19 targets (10 
nmolL−1) of the different genotypes in all the channels in order to prove 
that each B19 capture probe is specific for the detection of the specific 
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B19 genotype. It was found that CL signals above the cut-off value were 
observed only when the target analyte hybridized with the corresponding 
capture probe. 
Moreover it was observed that there are no aspecif signals when the 
biotin-labeled B19 negative control target was assayed with each capture 
probe (Fig. 4). 
 
Figure 4: CL images (left) and CL-profile signals (right) obtained from 
hybridization reactions between the three amino-linked B19 DNA probes 
and the three biotin-labeled artificial oligonucleotide B19 targets. The 
images show three reaction chips, each one arrayed with the three B19 
genotype-specific probes (three separate spots per genotype; genotype 1 
along the left, genotype 2 along the middle, and genotype 3 along the 
right microchannel) and hybridized with a defined B19 biotin-labeled 
target ((a) genotype 1, (b) genotype 2, and (c) genotype 3). 
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4.3.4 Analysis of amplified samples 
 
To evaluate the performance of the method, the product of amplification 
obtained from a B19 genotype 1 plasmid DNA was purified from reaction 
mix, fluorimetrically quantified, and then differently diluted (from 8×10−2 
to 50 nmolL−1) prior to analysis. 
The assay specificity on amplified products was confirmed as a CL signal 
above the cutoff value was detected only in the correspondence of the 
B19 genotype 1 capture probe.  
It was found a LOD value of 650 pmol L−1 that is slightly higher than that 
obtained for B19 targets (80 pmolL−1). Maybe this is due to a lower 
hybridization efficiency between oligonucleotide probe and amplified 
product, with respect to hybridization between single-stranded sequences 
of the same length. 
Finally amplified products obtained from ten reference serum samples 
were analyzed after PCR and scored as negative and positive, based on the 
cut-off value of the reaction chip. Our results (five negative and five B19 
genotype 1-positive samples) were confirmed by those obtained with the 
reference PCR-ELISA method. 
4.4 Conclusion 
 
The developed portable biosensor based on CL lensless imaging system, is 
able to detect and genotype B19 DNA. 
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It was designed and optimized a microfluidic reaction chip that comprises 
a PDMS microfluidic layer coupled with a glass slide on which genotype 
specific B19 capture oligonucleotide probes. 
Adsorbent pads facilitated the flow of the liquids along the PDMS channels 
exploiting capillary forces, thus realizing a selfpowered non-instrumented 
reaction chip. 
The assay takes only 30 min that is competitive with the reference 
microtiter plate DNA hybridization step of PCRELISA method that takes 2 
hours. 
Moreover the LOD was 80 pmolL−1 for the three different B19 genotype 
oligonucleotide targets and 650 pmolL−1 for the amplified product of DNA 
genotype 1, which is comparable to that obtained with standard laboratori 
methodologies (e.g., PCR-ELISA) and significantly improved with respect to 
the previously reported feasibility study [14]. Finally the performances of 
the methods were also confirmed by the analysis performed on ten serum 
samples.  
In conclusion the developed biosensor allows the simultaneous 
multiplexer and accurate quantification and genotypization of various 
DNA sequences in one sample employing relatively inexpensive 
instrumentation, suitable for POC applications. 
In the future i twill be possible to improve this prototype and to integrate 
a miniaturized PCR system [15] to perform on-chip both target DNA 
amplification and product denaturation prior to hybridization analysis. 
Moreover it is also possible to use this biosensor for the diagnosis  of 
different viral infections by  changing the arrayed probes. Indeed, for 
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various viruses the genotypization provides important information to 
assess therapeutic intervention and to predict the outcome of the disease. 
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A multiplex chemiluminescent biosensor for type B-fumonisins 
and aflatoxin B1 quantitative detection in maize flour 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reproduced from: “A multiplex chemiluminescent biosensor for type B-
fumonisins and aflatoxin B1 quantitative detection in maize flour” 
Martina Zangheri, Fabio Di Nardo, Laura Anfossi, Cristina Giovannoli, 
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5.1 Introduction 
 
The development of rapid and portable analytical devices for on-field 
screening applications is one of the most active trends in the field of 
agrofood analysis, since contamination with toxic substances (e.g., natural 
toxins, pesticides, veterinary drug residues, environmental pollutants) or 
microorganisms pose severe safety issues, as well as great economic 
concern.  
Immunochromatographic assays (also named lateral-flow immunoassays, 
LFIA) have shown to be particularly advantageous for such applications, 
since they provide rapid, simple, specific analyses with no instrumental 
requirement. Following their success in diagnostics, applications in 
agrofood screening is now an emerging field. In order to foster the use of 
LFIA methods as screening tools for food safety, two promising fields of 
research have been recently identified, namely the development of 
multiplex assays and their combination with portable recording devices 
[1]. Such features will enhance the competing ability of these portable 
tests with laboratory-based screening methods, directly providing on-field 
quantitative information on a number of analytes in a given sample. This 
will enable accurate screening of a large number of samples directly 
where they are obtained and significant savings in terms of time and costs, 
since only the actual suspicious samples will be transported to the 
analytical laboratory for confirmatory analyses. Aflatoxins and Fumonisins 
are secondary metabolites produced by Aspergillus and Fusarium 
respectively, growing on agricultural commodities in the field or after 
harvest [2]. Since mycotoxins represent one of the most important threat 
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for cereal safety [3], exhibiting acute toxic, carcinogenic, mutagenic, 
teratogenic, immunotoxic and estrogenic effects in man and animals [4,5], 
the European Commission (EC) has established maximum residue limits 
(MRLs) in cereals and cereal-based foods and feeds: 4000 g kg-1 for type 
B-fumonisin and 4 g kg-1 for the sum of Aflatoxins B1 (AfB1), B2, G1 and 
G2 as well as 2 g kg-1 for AfB16. 
A wide number of LFIA methods have been developed for mycotoxin 
detection in feed and food [1,7-9]. We recently reported a 
chemiluminescence (CL) LFIA-based biosensor for simple, rapid and 
ultrasensitive on-site quantification of type B-fumonisins in maize flour 
down to 25 µg kg−1, which has been successfully applied to both standard 
and real samples [10]. It is well known that enzyme-catalyzed CL detection 
provides high detectability, rapidity, specificity and wide linear range in 
immunoassays [11,12], especially in miniaturized formats [13]. This 
approach has been recently extended to LFIA methods, converting them 
from qualitative methods (when conventional colloidal gold labelling is 
employed) to highly sensitive and quantitative assays [14-16]. 
There is a growing demand for multiplex screening assays to replace 
single-analyte ones, since several mycotoxins may coexist in a single 
product and yield to synergistic toxic effects [2,7]. Despite 
immunochromatography technology potentially offers easy 
implementation of multi-residue analysis and obvious economic 
encouragement for this approach, few multiplex LFIA assays have been 
described in the literature up to now [8,17-21], and none of them 
exploited the advantages of CL detection.  
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Herein we report the development of a biosensor for the multiplex 
detection of type-B fumonisins and AfB1 in maize samples. The biosensor 
is based on a portable ultrasensitive CCD-based “contact” imaging device 
coupled with a CL-LFIA strip, on which two competitive immunoassays are 
simultaneously performed. Aflatoxin B1 conjugated with bovine serum 
albumin (AfB1-BSA) and Fumonisin B1 (FmB1)-BSA conjugate were 
immobilized in different positions along the strip. Upon sample 
application, type-B fumonisins and AfB1 in the sample competed with 
immobilized analogues for their specific anti-fumonisin or anti-aflatoxin 
antibodies added to the sample. Signal detection was performed by CL 
contact imaging upon addition of a secondary horseradish peroxidase 
(HRP)-labelled secondary antibody and the suitable enzyme CL substrate. 
With this format, a quantitative and objective measurement of target 
analytes below EU regulatory levels was performed, thus enabling rapid 
and reliable identification of those samples requiring confirmatory 
analysis. 
 
5.2 Materials and methods 
5.2.1 Reagents 
 
FmB1, AfB1, Aflatoxin B2, Aflatoxin G1, Aflatoxin G2, Ochratoxin A, 
Deoxynivalenol, and Zearalenone (Oekanal certified solutions), BSA, 
Tween-20 and HRP-labeled goat anti-rabbit immunoglobulin were 
purchased from Sigma Aldrich (St. Louis, MO, USA). Ultrapure water was 
produced by a Millipore Milli Q system (Millipore, Bedford, MA). The 
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Supersignal ELISA Femto CL substrate for HRP was bought from Thermo 
Fisher Scientific Inc. (Rockford, IL). 
FmB1 and AfB1 powder were purchased from Fermentek (Jerusalem, 
Israel). The goat anti-rabbit antibody was purchased from AbCam 
(Cambridge, UK). Rabbit anti-FmB1 antibodies and rabbit anti-AfB1 
antibodies were kindly supplied by Generon srl (Modena, Italy). The other 
reagents were of analytical grade and were employed as received. 
Phosphate buffered saline (PBS) was prepared as follows: 10 mmol L−1 
Na2HPO4, 2 mmol L
−1 KH2PO4, 137 mmol L
−1 NaCl, 2.7 mmol L−1 KCl, pH 7.4. 
Assay strips for LFIA were prepared by immobilizing on nitrocellulose 
membranes, from bottom to top of the strip, the FmB1-BSA conjugate, the 
AfB1-BSA conjugate, and the goat anti-rabbit antibody to form the two 
test lines (T-lines) and the control line (C-line), respectively, keeping a 
distance of 4 mm between the lines (Fig. 1, Panel C). The membranes were 
then assembled with a sample and an adsorbent pad and cut into sections.  
5.2.2 Preparation of mycotoxin-BSA conjugates 
 
The FmB1-BSA conjugate was synthesized according to Christensen et al. 
[22], with slight modifications. The AfB1-oxime hapten (AfB1-CMO), 
synthesized according to Kolosova et al. [23], was employed for the 
preparation of the AfB1-BSA conjugate by the N-hydroxysuccinimide ester 
method as follow: 5.7 mg of AfB1-CMO were reacted overnight at room 
temperature with 5 mg of BSA dissolved in 0.15 M sodium bicarbonate pH 
8.3 and the pure conjugate was obtained from gel-filtration, as described 
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above. AfB1-BSA concentration was determined through Brilliant Blue 
Comassie method.  
Conjugates were supplemented with 0.1% sodium azide and stored 
refrigerated. 
5.2.3 Instrumentation 
 
The biosensor, shown in Fig. 1 (Panel B), was assembled employing a 
previously described CCD-based contact imaging configuration [10,24]. In 
particular, the LFIA strip was placed directly in contact with the 
thermoelectrically-cooled CCD sensor through a round fiber optic taper. A 
mask was used to ensure reproducible strip positioning. This assembly was 
enclosed in a dark box to provide shielding from ambient light. During the 
acquisition the CCD sensor temperature was kept at −10 ◦C. 
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Figure 1: Top: a scheme of the multiplex CL-LFIA assay on the 
nitrocellulose strip. Bottom: a CCD-based device in a contact imaging 
detection format for acquiring CL signals from LFIA strips; a 
chemiluminescence image and intensity profile of a nitrocellulose 
membrane where adjacent lines were immobilized at a 4 mm distance. 
 
5.2.4 Assay procedure 
 
The nitrocellulose strip was placed horizontally on the larger fiber optic 
taper surface, then the LFIA assay was started by depositing on the 
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bottom of the strip a volume of 100 L of solution, containing 40 L of PBS 
with 3% BSA (w/v) and 0.1% Tween 20 (v/v), 5 L of HRP-labeled goat anti-
rabbit antibody diluted 1:500 (v/v) in PBS, 5 L of rabbit anti-FmB1 and 
anti-AfB1 antibody, each diluted 1:500 (v/v) in PBS, and 50 L of maize 
sample extract (or blank maize sample extract for the blank, or FmB1 and 
AfB1 standard solutions prepared in blank maize sample extract to 
produce calibration curves). Upon complete migration of the solution (10 
min), the strip was washed by flowing 100 L of PBS for 10 min. Then 70 
L of CL substrate was added at the bottom of the strip and let flow 
through the membrane (4 min), which was kept at 25 °C. The CL signal was 
acquired with the contact CCD-based imaging device (5-s acquisition 
time). Total analysis time was about 30 min. The scheme of the multiplex 
CL-LFIA assay on the nitrocellulose strip is showed in Fig. 1 (Panel A). To 
obtain quantitative information, the mean photon emission was measured 
in the areas corresponding to C-line and T-lines of the LFIA strip and each 
was subtracted of the mean background signal measured in two adjacent 
areas below and above the line.  The T-line/C-line ratio was calculated for 
each analyte and then converted into B/B0 ratio by dividing it for the T-
line/C-line ratio measured in the absence of the target analyte (B0, i.e., 
maximum T-line/C-line value). Calibration curves were obtained by 
plotting B/B0 values against the log of analyte concentration and fitting 
the experimental data with a four-parameter logistic equation. 
Linearization of the calibration curve was obtained through the logit–log 
transformation, by plotting the logit of the B/B0 ratio (as a percentage) 
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against the log of analyte concentration. The best data fit was obtained by 
linear regression of the standard points.  
5.2.5 Analysis of maize samples 
 
Maize flour samples were obtained directly from producers or mills. 
Fumonisin content was determined by HPLC-UV as previously described 
[25]. AfB1 contamination was assessed by a commercial ELISA kit 
(EuroClone SpA, Milano, Italy). 
Maize flour samples were subjected to a pre-analytical extraction 
procedure previously described [10]. Briefly, 1 g of maize flour was 
suspended in 10 mL of PBS buffer, hand-shaken for 3 min at RT and let 
settle for 5 min. Then, a 100-L aliquot of the supernatant was heated for 
3 min at 100 °C to inactivate endogenous maize peroxidase, then cooled 
to room temperature and subjected to analysis by LFIA. Heating was 
performed on a indium-tin oxide (ITO)-coated glass (SPI Supplies/Structure 
Probe Inc., West Chester, PA) employing a Frame-Seal slide chamber (Bio-
Rad Laboratories, Hercules, CA) to contain the sample and avoid 
evaporation. To obtain the analyte concentration value for each sample, 
its B/B0 value was calculated as described above and interpolated on a 
stored calibration curve. 
5.3 Results and discussion 
 
A duplex indirect competitive CL-LFIA was developed by depositing on a 
test strip AfB1-BSA and FmB1-BSA on T-lines and goat anti-rabbit antibody 
on a unique C-line. With this format, each of the two analytes present in 
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the sample competes with its corresponding immobilized hapten for 
binding the specific anti-AfB1 or anti-FmB1 rabbit antibodies, which are in 
turn detected by employing HRP-conjugated anti-rabbit antibody and CL 
detection. Anti-rabbit antibodies immobilized on the C-line allow 
confirmation of correct test development by capturing any rabbit-
antibody-based signal reagent (i.e. the presence of the signal indicated the 
correct migration of the reactants along the strip). Moreover, normalizing 
the signal of T-lines respect to that of C-line, make it possible to take into 
account environmental and matrix factors that might affect the intensity 
of the CL signal (i.e. changes in ambient temperature or the presence of 
HRP inhibitors in the sample) providing a strip-to-strip normalization 
factor.  
Signals were detected employing an ultrasensitive cooled CCD sensor 
employed in a “contact imaging” approach, as previously described. As 
shown in Figure 1C, 4-mm distance between adjacent lines was sufficient 
to prevent interference in signal detection. According to the competitive 
immunoassay principle, the light emission intensity of the T-lines gradually 
decreased up to their complete disappearance as the concentration of the 
respective analyte in the sample increased. The C-line intensity was 
employed as a normalization value, to increase assay reproducibty and 
compensate for test strip to test strip variability. 
5.3.1 Optimization of experimental parameters 
 
Assay parameters (concentration of immunoreagents and selection of the 
saturation agent) were optimised to generate assays with limits of 
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detection (LOD) and dynamic ranges useful for detecting AfB1 and FmB1 
in maize samples below regulatory limits. Furthermore, the methods were 
optimized considering that, in order to detect simultaneously both 
analytes, the three lines on a strip should provide similar signal intensity. 
This ensures the possibility to use a single integration time for the 
simultaneous measurement of the CL signals on a strip, preventing cross-
talk phenomena.  
The concentrations of primary and secondary antibodies yielding the 
highest detectability for FmB1 and AfB1 were evaluated. The optimal 
concentration of anti-fumonisin (1:500 v/v), anti-aflatoxin (1:500 v/v) and 
HRP-labelled anti-rabbit (1:500v/v) were selected as the dilution that 
provides the highest detectability and the best compromise between the 
effects described above. Furthermore, different protocols were assayed 
for saturating the nitrocellulose membrane, thus reducing nonspecific 
adsorption of the immunoreagents and increasing the signal intensity of 
the lines, as previously shown [25]. In particular, different saturation 
agents (BSA, non fat dry milk, soybean milk) and additives in the running 
buffer were tested. The best performance was obtained by incubating the 
nitrocellulose strips with 1% BSA (w/v) in PBS buffer for 5 min at room 
temperature and by adding 3% BSA (w/v) and 0.1% Tween 20 (v/v) in the 
running buffer.  
Finally, the absence of cross reactivity (CR) between the two analytes was 
checked by running each primary antibody in the absence of analytes in 
solution. As shown in Fig. 2, no CR between anti-fumonisin antibody and 
AfB1 (left panel), nor between anti-aflatoxin and FmB1 (right panel) was 
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observed, as confirmed by the absence of the upper and lower T-lines, 
respectively. 
 
Figure 2: Chemiluminescence images and intensity profiles of 
nitrocellulose membranes in which anti-aflatoxin and anti-fumonisin 
antibodies separately ran in the absence of analytes. 
 
5.3.2 Specificity of the immunoreagents 
 
The specificity of the immunoassays was determined towards structurally 
related and unrelated mycotoxins by measuring the IC50 value for each 
compound of interest, i.e., the concentration of tested compound 
providing a response at the 50% bound (midrange of the curve). The CR 
values were calculated as the ratio of the IC50 value for the analyte over 
the IC50 value of the tested interfering compound. The anti-aflatoxin 
antibody showed low CR with AfG2 and AfB2 (below 2%) and higher for 
AfG1 (38%). The anti-fumonisin antibody showed about 100% CR with 
FmB2, thus showing its ability to detect type-B fumonisins present in the 
sample, as the sum of FmB1 and FmB2. 
Both antibodies showed very low CR towards Zearalenone, 
Deoxynilvalenol, and Ochratoxin A, as shown in Table 1.  
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The characteristics of the employed antibodies make the multiplex assay 
particular relevant for regulatory purposes. Indeed, EU regulations define 
limit values for fumonisin as the sum of FmB1 and FmB26. In addition, 
while limit values for aflatoxins are reported as the sum of AfB1, AfB2, 
AfG1, and AfG2, it is important to note that the ability to singularly detect 
the concentration of AfB1 is particular relevant, being this mycotoxin 
listed as a group 1 carcinogen by the International Agency for Research on 
Cancer [4]. Finally, negligible CR of the antibodies towards structurally 
unrelated mycotoxins considerably reduces the risk for false positive 
results.  
 Anti-fumonisin 
antibody 
Anti-aflatoxin antibody 
Fumonisin B1 100% <0.02% 
Fumonisin B2 97% <0.02% 
Aflatoxin B1 <0.02% 100% 
Aflatoxin B2 <0.02% 2% 
Aflatoxin G1 <0.02% 2% 
Aflatoxin G2 <0.02% 38% 
Zearalenone <0.02% 0.2% 
Deoxynilvalenol <0.02% 0.8% 
Ochratoxin A <0.02% 2% 
 
Table 1: Cross reactivity values measured for the anti-fumonisin and anti-
aflatoxin antibodies 
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5.3.3 Calibration curves  
 
Calibration curves were generated by using standard solutions produced 
in blank maize flour sample extracts in the range between 0.2 - 1500 g L-1 
and 0.06 - 50 g L-1 of FmB1 and AfB1, respectively. Calibration curves 
were produced first by working in single assay; in particular both primary 
antibodies were added in all the strips, while the two analytes were 
assayed separately. As shown in Fig. 3, being a competitive type format, 
the decrease of T-line/C-line ratio was directly proportional to the amount 
of the analyte in the sample (the T-lines completely disappeared at the 
highest FmB1 and AfB1 concentration).  
 
Figure 3: (A) Calibration curve obtained for AfB1 and FmB1 employing the 
contact imaging detection device. The curve fitting was performed 
employing a four-parameter logistic equation. Error bars_ ± SD, n _ 3. (B) 
Chemiluminescence images of LFIA membranes acquired with the 
contact imaging detection device. 
 
The limit of detection (LOD) was calculated as the concentration 
corresponding to the blank T-line/C-line value minus three times the blank 
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standard deviation. The obtained values were 0.6 g L−1 FmB1 and 0.15 g 
L−1 AfB1, corresponding respectively to 6 g kg−1 and 1.5 g kg−1 in maize 
flour samples (according to the extraction procedure employed in this 
work). The dynamic range of the method extended from 0.6 to 1500 g L−1 
for FmB1 and from 0.15 to 50 g L−1 for AfB1, with a midpoint value at 40 
g L−1 and 0.9 g L−1, respectively.  
The LOD values obtained for FmB1 and AfB1 are comparable or lower than 
the those reported in the literature employing a CL-LFIA [10] or colloidal 
gold based LFIA assays [25-28], as well as when compared with 
commercial assays. The obtained results are comparable with those of 
recently published articles which describe the use of indirect competitive 
LFIA based on colorimetric detection for a multiple semi-quantitative 
determination of Fusarium mycotoxins in cereals [19] and for the 
simultaneous quantification of ZEA and FmB1 in corn and wheat [18]. The 
results of repeated calibration curves demonstrated a good 
reproducibility, the relative standard deviation associated to each point of 
the calibration curve being 0.5-12 % for FmB1 and 0.5-7% for AfB1, 
respectively (3 calibration curves produced in separate runs for each 
analyte). Finally, calibration curves obtained separately for each analyte 
(although in the presence of both primary antibodies) were compared 
with those obtained by working in multiplex format, adding in the same 
sample known amounts of both FmB1 and AfB1. To evaluate the 
possibility of accurately detecting each analyte, even when one is present 
at a higher concentration with respect to the other, multiplex calibration 
curves were generated either by increasing the amount of both analytes 
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simultaneously, or by increasing the concentration of one analyte while 
decreasing that of the other. A representative series of CL images and the 
obtained calibration curves are shown in Fig. 4.  
Results show that the simultaneous presence of the two analytes in the 
sample, even in disproportionate amounts, does not affect the light 
emission intensity of the other test line. 
The LOD and the dynamic range obtained in monoplex format were 
confirmed also by working in multiplex assay, making it possible to detect 
and quantify the two mycotoxins in a unique analysis. This indicates that 
multiplex competitive assays on a single test strip can produce 
quantitative assays without loss in assay detectability as compared with 
single tests. 
 
Figure 4: Chemiluminescence images and intensity profiles of LFIA 
membranes obtained by increasing the concentration of one analyte and 
decreasing the other (A) and increasing the amount of both analytes 
simultaneously (B). 
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5.3.4 Maize flour samples  
 
To enable multiplex assays in a point-of-use format, a simple and rapid 
sample preparation procedure, providing good recovery for all the 
analytes of interest, must be employed. It has been previously shown that 
extraction in aqueous media at close to neutral pH values provides good 
recovery for both aflatoxins [26] and fumonisins [25]. Furthermore, the 
absence of organic solvents in the extraction solution makes the 
procedure more environmental-friendly and avoids problems of disruption 
of antigen-antibody binding. Thus, maize flour samples were subjected to 
extraction in PBS buffer, followed by rapid extract heating to inactivate 
peroxidase enzymes naturally present in maize (which was performed 
employing a portable system suitable for point-of-use applications). The 
whole analytical procedure, including sample preparation, lasted 30 min. 
The assay analytical performance was evaluated by analyzing pooled 
extracts from blank maize flour samples (previously analyzed by ELISA) 
fortified by adding known amounts of both FmB1 (166, 18 and 2 g L-1) 
and AfB1 (1.8, 0.6 and 0.2 g L-1), corresponding approximately to 0.9, 0.6 
and 0.3 B/B0 values on the respective calibration curve. Recovery ranged 
from 79 to 119%, while coefficients of variation below 20% were obtained 
(Table 2). The performance of the multiplex LFIA method was also 
evaluated on real samples and results were compared with those obtained 
by confirmatory analyses, performed by HPLC-UV (FmB1 + FmB2 content) 
and a commercial ELISA kit (AfB1). Results, reported in Table 3 show a 
good agreement between CL-LFIA and reference methods for both 
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mycotoxins in all samples, with recovery values ranging from 89 to 120% 
and coefficient of variation below 20%. A picture of the membranes used 
for the analyses of the maize samples is reported in Fig. 5. 
 
Figure 5: Chemiluminescence images of LFIA membranes used for 
analyses of maize samples. The membrane A is negative for all toxins, B is 
positive for AfB1 and C is positive for typeB-Fm. 
 
5.4 Conclusions 
 
The results show that the multiplex biosensor provides reliable, with 
performances comparable with those obtained employing reference 
methods. The extraction procedure fulfils the requirements for the 
development of a method that can be applied on site. The co-extraction of 
the two mycotoxins, although based on a simple manual extraction with 
aqueous buffer and rapid heating system employing a portable manifold, 
shows satisfactory recoveries. The method is rapid (total analysis time 30 
min), simple, cost effective and can be performed in a non-laboratory 
environment by non-specialists. 
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The possibility to detect simultaneously two analytes, providing 
quantitative results within current regulatory limits, reduces the number 
of analysis and allows to screen on site a large number of samples, thus 
reducing the costs for transporting and analyzing samples in the 
laboratory. This allows performing frequent analyses monitoring the 
entire production chain (e.g., on field, at harvest, during storage and 
transportation) according with the HACCP procedures. In the future, it will 
be possible to further increase the number of analytes by adding other 
test lines, provided the compatibility with the antibody employed in the 
immunoassay. 
Ongoing work is devoted to the development of a ready-to-use cartridge 
containing the LFIA strip and all the reagents necessary per a complete 
analysis, in order to facilitate on-field applications. 
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Expected 
concentration 
(g L-1) 
CL-LFIA 
(g L-1) 
Recovery 
(%) 
Expected 
concentration 
(g L-1) 
CL-LFIA (g 
L-1) 
Recovery 
(%) 
(A) Maize flour extracts fortified with 
Fumonisin B1 and Aflatoxin B1 
(B) Maize flour samples 
Fumonisin Fumonisin 
166 148 
(CV%=5) 
89 470 480 
(CV%=20) 
102 
18 15 
(CV%=15) 
83 80 87 
(CV%=12) 
109 
2.0 2.3 
(CV%=13) 
115 10 12 
(CV%=15) 
120 
Aflatoxin Aflatoxin 
1.8 1.7 
(CV%=19) 
94 0.45 0.43 
(CV%=10) 
96 
0.60 0.69 
(CV%=12) 
116 0.57 0.58 
(CV%=10) 
102 
0.21 0.20 
(CV%=14) 
95 0.50 0.44 
(CV%=15)  
88 
 
Table 2: Results obtained in the analysis of maize flour samples by CL–LFIA 
biosensor. (A) Fortified samples were produced by adding known amounts 
of fumonisin B1 and aflatoxin B1 to a blank maize sample extract. (B) 
Maize flour samples, previously analyzed by HPLC-UV and ELISA, were 
subjected to extraction and analyzed by CL–LFIA biosensor. CL–LFIA data 
are expressed as mean and CV% of three independent measurements. 
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CHAPTER 6 
 
 
A simple and compact smartphone accessory for quantitative 
chemiluminescence-based lateral flow immunoassay for 
salivary cortisol detection 
 
 
 
 
 
 
 
 
 
 
Reproduced from: “A simple and compact smartphone accessory for 
quantitative  chemiluminescence-based lateral flow immunoassay for 
salivary cortisol detection”  
Martina Zangheri, Luca Cevenini, Laura Anfossi, Claudio Baggiani, Patrizia 
Simoni, Fabio Di Nardo, Aldo Roda 
Biosensors and Bioelectronics, 2015, 64:63-68 
Reproduced by permission of Springer (License number 3580670111372) 
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6.1 Introduction 
 
The development of an accurate and user-friendly diagnostic device for 
“point-of-care” (POC) applications is one of the most challenging 
objectives in field of analytical chemistry. The requirements for POC 
devices are the portability, quickness, and easiness to use. Moreover in an 
integrated, self-standing device, they should be able to perform the entire 
analytical process, from sample pretreatment to measurement and data 
processing. Among the different analytical techiniques, the methods 
based on immunological reactions are suitable for this purpose because 
their high specificity and sensitivity makes it possible to detect clinical 
biomarkers even at low concentrations and in complex matrices. A 
suitable platform for immunological methods is the  paper-based 
technology. Infact this devices are low cost and easy to handle, thanks to 
the use of capillary force for fluid transport and delivery without external 
power [1-6]. Of the paper-based analytical methods, lateral flow 
immunoassays (LFIAs), are one of the most commercially feasible 
analytical tools for rapid and portable clinical immunodiagnostics [2,7] 
such as diagnosing  blood infections or contamination, drug abuse, or for 
ascertaining pregnancy [5]. 
Since LFIA was principally used for qualitative analysis, in recent years, this 
format has been combined with portable instruments that provide 
quantitative sensing based on the use of portable photometric strip 
readers to measure the lines’ colour intensity [8-10] or by using 
alternative labels, such as enzymes [11], fluorescent nanoparticles [12-14], 
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electrochemical measurements [15,16], and more recently 
chemiluminescence detection of horseradish peroxidase (HRP) labelled 
reagents [17-21]. The use of CL  detection is ideal for miniaturization and 
POC biosensor development because of its inherent sensitivity and 
simplicity. Organic photodiodes (OPDs) [22] and miniaturized 
hydrogenated amorphous Silicon photodiode array [23] and have been 
recently proposed as a versatile and low-cost technology that allow to 
develop miniaturized devices with high detectability and sensitivity. 
Another approach for CL detection is light imaging with a charge-coupled-
device (CCD) or complementary metal-oxide semiconductor (CMOS) 
sensor, providing  not only a measurement of emitted photons, but also 
the 2D image of the reaction chip [24] allowing spectral and spatial 
resolution. Nowadays, the sensitivity of the back side illuminated CMOS 
(BSI-CMOS) used in new generation of smartphone camera mean it can be 
used as a CL detector. Moreover, it is possible to exploit the connectivity 
and data processing offered by smartphones to perform analysis directly 
at the point of need with simple procedures. A system like this could 
eventually be used to monitor patient health and directly notify the 
physician of the analysis results in real time leading to a decrease costs 
and increase the healthcare availability and accessibility [25,26].  
The use of smartphone for colorimetric LFIA method was recently 
reported [27,28] but until now, the use of CL detection and smartphone 
technology for LFIA methods has not been reported. 
The aim of this work was to developed a portable analytical device that 
transforms a smartphone into a CL detector for quantitative LFIA analysis. 
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Using a low cost desktop 3D printer, we developed the analytical device 
that comprises a smartphone equipped with custom-designed accessories. 
The accessories are a cartridge that houses the LFIA membrane and a 
smartphone adaptor, containing a plano-convex lens aligned with the 
camera and a slot for inserting the cartridge. Once the operator has 
carried out the assay on the LFIA strip, both the smartphone and the 
cartridge are inserted into the assembled cradle to perform the 
measurement. A specific photography Application and the camera’s 
autofocus system were used to obtain an high quality image of the sensing 
surface. 
The performance of the system were evaluated by quantitative detection 
of salivary cortisol, which is considered a biomarker of stress, anxiety, and 
depression [29,30].  Since salivary levels of cortisol are very low in saliva 
matrix (at least a factor 10 with respect to plasma levels) [31], the 
developed assay must be highly sensitive and accurate. We optimized a 
competitive immunoassay, in which cortisol in saliva and horseradish 
peroxidise (HRP)-cortisol conjugate compete for anti-cortisol antibody 
immobilized on the nitrocellulose membrane. The HRP-cortisol bound to 
antibody will be detected using a chemiluminescent substrate based on 
luminol/H2O2 and enhancers.  
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6.2 Materials and methods 
6.2.1 Reagents 
 
The Supersignal ELISA Femto CL substrate for HRP was purchased from 
Thermo Fisher Scientific Inc. (Rockford, IL). Polyclonal anti-cortisol 
antibody produced in rabbit was purchased from Analytical Antibodies 
(Bologna, Italy). HRP-conjugate cortisol was obtained from Diametra 
(Milano, Italy). Cortisol standard solution, polyclonal anti-peroxidase (HRP) 
antibody produced in rabbit, bovine serum albumin (BSA), and Tween-20 
were purchased from Sigma Aldrich (St. Louis, MO, USA). Salivettes cotton 
swabs for the saliva sampling were purchased from Sarstedt, Germany. 
The Silgard 184 polydimethylsiloxane prepolymer and the curing agent 
were obtained from Dow Corning (Midland, MI). The other reagents were 
of analytical grade and were used as received. 
Assay strips for LFIA were prepared by immobilizing on nitrocellulose 
membranes the rabbit anti-cortisol antibody (T-line) and the rabbit anti-
peroxidase antibody (C-line) keeping a distance of 5 mm between the two 
lines. The membranes were then assembled with a sample and an 
adsorbent pad and cut into sections.  
6.2.2 Preparation of immunochromatographic test strip  
 
Nitrocellulose membranes (Hi-flow plus 180 membrane cards from Merck 
Millipore, Billerica, MA) for LFIA strip were prepared employing a XYZ3050 
platform (Biodot, Irvine, CA), equipped with two BioJet Quanti™ 3000 Line 
Dispenser for non-contact dispensing. In particular, from bottom to top of 
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the strip, the anti-cortisol antibody (1:50 v/v) and the anti-HRP antibody 
(1:500 v/v) diluted in PBS (20 mM phosphate buffer, pH 7.4), were 
dispensed to form the T-line and the C-line, respectively. Reagents were 
deposited at 1μL cm-1, keeping a distance of 5 mm among the lines. 
Membranes were dried at 37°C for 60 minutes under vacuum, then the 
nitrocellulose surface was saturated with 1% BSA (w/v in PBS), washed 
with PBS supplemented with 0.05% of Tween 20, and finally dried at 37°C 
for 120 min under vacuum. Membranes were assembled with a glass fiber 
pad as the sample pad (Whatman Standard 14® from GE Healthcare 
Europe, Milan, Italy) and a cellulose pad as the adsorbent pad (Merck 
Millipore, Billerica, MA), with 1-2 mm of overlap between one and the 
other. Assembled membranes were cut into strips (5 mm width) by means 
of a CM4000 guillotine (Biodot, Irvine, CA) and stored in a desiccator at 
room temperature. 
6.2.3 LFIA assay principle and format  
 
It was developed an indirect competitive CL-LFIA assay. Cortisol in sample 
or standard solutions and HRP-cortisol conjugate migrate along the 
nitrocellulose membrane strip by capillarity. Upon the reaching the area 
corresponding to T-line, where the anti-cortisol antibody was immobilized, 
the cortisol in the sample compete with HRP-cortisol for binding a fixed 
and limited amount of immobilized anti-cortisol antibody. The unbound 
reagents HRP-cortsol conjugate are then captured by immobilized anti-
HRP antibody (C-line). In the detection step, a CL substrate for HRP was 
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added to the strip and the resulting CL signal was imaged using the 
smartphone camera. 
The intensity of the CL signal of the T-line is inversely related to the  
amount of cortisol and  allowed to quantify the amount of cortisol in the 
sample. For quantitative analysis, the CL signal of the T-line was 
normalized with respect to that of the C-line of the same strip inorder to 
take into account environmental and matrix factors that might affect the 
intensity of the CL signal, such as changes in ambient temperature or the 
presence of HRP inhibitors in the sample. As with qualitative colorimetric 
LFIAs, the CL signal of the C-line was also used to assess the validity of the 
assay (i.e. an intense signal indicated the correct migration of the 
reactants along the strip). 
6.2.4 Smartphone accessory 
 
Smartphone adaptor and LFIA cartridge were made using the Makerbot 
Replicator 2X (Makerbot, Boston MA, USA). As printing material 
thermoplastic black and yellow acrylonitrile butadiene styrene (ABS) 
polymers were used. 3D models were created using the browser-based 3D 
design platform Tinkercad. The MakerWare slicer software was used to 
define printing options and settings. The smartphone accessories are 
showed in Figure 1. The smartphone adaptor was designed for the 
Samsung Galaxy SII Plus smartphone (Fig. 1c). It holds a plano-convex lens 
of 6mm diameter (Edmund Optics, York, UK) in contact with the phone 
objective and houses an LFIA cartridge (8 cm length, 2.5 cm width and 1cm 
thickness), preventing ambient light interference in the camera objective. 
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The LFIA cartridge (Fig. 1a) houses a nitrocellulose strip (Fig. 1b) and 
contains a 25 µl reservoir for HRP-cortisol conjugate solution, two 
separate 100 µl reservoirs for CL substrate and PBS, and an inlet for 
sample injection. The cartridge was printed in two separate pieces in 
order to insert the strip and reagents. A lid provides an optical window for 
signal acquisition and a grid allows evaporation of the absorbent pad. 
The analytical performance of the smartphone camera was compared with 
that of a conventional laboratory ultrasensitive imaging instrument, the 
Night OWL LB 981 luminograph (Berthold Technologies GmbH & Co KG, 
Bad Wildbad, Germany) equipped with a conventional lens-based optics 
and a highly sensitive, back-illuminated, double-Peltier-cooled, black and 
white CCD camera previously developed in our laboratory [32,33], since 
this approach has not previously been used to acquire CL signals from LFIA 
membranes. 
 
 
Figure 1: (a) 3D printed (ABS) cartridge, housing the LFIA strip; (b) LFIA 
nitrocellulose strip with control- (C-line) and test-lines (T-ine); (c) 3D 
printed smartphone accessory comprising a plano-convex lens holder and 
the LFIA cartridge adaptor. 
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6.2.5 Sample and spiked sample preparation 
 
Saliva samples were collected from healthy volunteers at 8 AM before 
eating, while the saliva used for the calibration curves was collected at 9 
PM, when cortisol concentration is usually lower due to circadian 
variation. To establish the calibration curves in saliva, several dilutions of 
cortisol were added to saliva to obtain the desired concentrations 
(between 0 and 100 ng/mL). The confirmatory analysis on real samples 
were performed using a commercial ELISA kit (Cortisol saliva ELISA, 
Diametra, Milan, Italy).  
6.2.6 Assay procedure 
 
Firstly saliva samples were collected by resting an adsorbent swab inside 
mouth until it was saturated (60-90 seconds) and then, the swab was 
placed into a syringe for immediate compression. A small volume of saliva 
sample (25L) was transferred into a prefilled well, positioned near to the 
sample pad, through a PDMS-based injection septum. The syringe needle 
penetrated through the PDMS layer and the sample was mixed up with 
the prefilled solution of HRP-cortisol conjugate diluted 1:100 (v/v) in PBS 
containing BSA 6% and Tween 0.2%. 
Upon the injection of the sample, the mixed solution reached the sample 
pad and it began to flow across the membrane where the 
immunoreactions take place. After the complete migration of the solution 
(15 min), a washing step was performed by flowing 50 L of PBS for 10 
min. Then, the strip was wetted by 100 L of CL substrate, stored in a 
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reservoir placed near the nitrocellulose membrane. Finally the cartdtrige 
is inserted into the slot on the phone’s cover (Fig. 2) and then  the CL 
signals were acquired (10 seconds) using a professional camera 
application for mobile devices (Camera FV-5 Lite). To obtain quantitative 
information, a calibration curve was generated using cortisol standard 
solutions prepared in saliva matrix. 
The elaboration of the signal was performed using Using ImageJ software 
 v.1.46 (National Institutes of Health, Bethesda, MD). In particular, the 
mean photon emission intensity was measured in the areas corresponding 
to C-line and T-line of the LFIA strip. Each was subtracted from the mean 
background signal measured in adjacent areas. The T-line/C-line ratio was 
calculated for each concentration and then converted into B/B0 ratio by 
dividing it for the T-line/C-line ratio measured in the absence of the target 
analyte (B0, i.e. maximum T-line/C-line value). By plotting B/B0 values 
against the log of analyte concentration calibration curves described by a 
four-parameter logistic function were obtained.  
To obtain the analyte concentration in real samples, B/B0 value was 
calculated as described above and interpolated on a stored calibration 
curve. 
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Figure 2: The integrated cortisol  LFIA smartphone based device with 
running Camera FV-5 lite application for CL signal acquisition and the CL 
image of the sensing surface. 
 
6.3Results and discussion  
6.3.1 Smartphone camera detectability and resolution  
 
To evaluate the imaging resolution and assess the possibility of accurately 
measuring the photon emission from a T-line on the strip without any 
significant interference from the adjacent C-line, the strips were imaged 
using both the reference LB-981 luminograph and the smartphone’s 
camera (Fig.3) equipped with the developed mini darkbox accessory. It 
was observed that there is no significant crosstalk measuring the CL 
intensity of each line using smartphone camera. The performances 
showed by smartphne camera are comparable to those obtained using a 
bench-top luminograph. The peaks of the CL intensity profiles measured 
across the lines are resolved at the baseline, even in the case of a 
disproportion of CL intensity between the light intensities of the two 
adjacent lines. The detectability offered by smartphone camera is only one 
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decade less compared with those obtained using the CCD camera or 
organic photodiodes [22]. It is important to point out the fact tat the CCD, 
differently from the smartphone camera, is cooled at -40 °C and presents 
larger pixel size. Anyway the detectability offered by BSI-CMOS 
smartphone camera is adequate for measuring the light signal from the 
LFIA strip at the relevant cortisol concentration. New generation of 
smartphones is based on colour BSI-CMOS that is much more sensitive 
than previous front-illuminated sensors, with an increase of the amount of 
captured light from about 60% to over 90% (Swain and Cheskis, 2008), 
making it possible to improve low-light imaging performance. Moreover, 
the smartphone could be used as an integrated platform that allows to 
acquire and also to process the signal together with the possibility of 
direct connectivity (bluetooth, wifi) for data managing and sharing.  
 
 
Figure 3: Comparison of CL images acquired with a Berthold Nigh Owl 
luminograph (left) or the smartphone camera (right). The insensity profile 
and image resolution of the two instrumentation are presented.  
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6.3.2 Concentration of immunoreagents 
 
In order to generate an assay with a detection limit and dynamic range 
suitable for measuring cortisol in the relevant physiological range in saliva 
samples, concentration of  HRP-cortisol conjugate was optimized. For 
preventing the interferences between CL signals of C-line and T-line,  they 
must have similar signals in order to use a single integration time to be 
simultaneously measured. For the optimization of HRP-cortisol conjugate 
concentration, blank samples and samples containing 1 and 10 ng/ml were 
assayed in presence of different dilutions of HRP-cortisol conjugate. As 
shown in Fig. 4 a decrease in the concentration of the HRP-cortisol 
conjugate employed in the assay in the range between 1:50 and 1:1000 
(v/v) caused a decrease in the CL emission of the T-line. This was 
associated to an increase in the ability of cortisol to displace the HRP-
cortisol conjugate from the immobilized anti-cortisol antibody, as shown 
by a decrease in the ratio T-line/C-line obtained in the presence and in the 
absence of cortisol in the sample. An higher dilution of the HRP-cortisol 
conjugate results in a significant decrease in the CL signal for the 
concentration of 10 ng/mL cortisol, shortening the dynamic range and 
making not possible to quantify higher cortisol levels. The dilution that 
provides the best compromise between these effects was 1:100 v/v.  
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Figure 4: Chemiluminescence signals obtained employing different 
dilutions of HRP-cortisol conjugate. Assays were performed in the absence 
of cortisol (white symbols) or in the presence of cortisol 1 ng/mL (black 
symbols) and 10 ng/mL (grey symbols).  
 
6.3.3 Chemiluminescent signal kinetics 
 
The kinetics of the HRP-catalyzed CL emission in the presence of luminol-
based substrates containing suitable enhancers reaches a steady state CL 
intensity in a short time [34,35]. Since the migration along the whole LFIA 
membrane requires 15 minutes, it might result in partial inactivation of 
HRP, especially in the presence of intense CL signals. In order to overcome 
this problem, the CL substrate was applied directly to the nitrocellulose 
membrane, avoiding excessively long migration times along the whole 
strip. To estabilish the suitable integration time, measurement of the CL 
signals at different integration times (from 2 to 20s) were performed, 
founding that 10 s was sufficient to achieve the maximum CL signal, thus 
this time was used for the analysis. Infact, using an integration time lower 
than 10 s, the intensity of the CL signal decreases considerably, while a 
higher integration time does not significantly enhance the intensity of the 
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signal itself. Upon the achievement of the steady state it lasts for about 1 
min, confirming that an excess of substrate was present on the LFIA 
membrane and ensuring that the CL signal intensity was proportional to 
the enzyme amount. The kinetic of the CL signal is reported in Fig. 5. 
 
 
Figure 5: Kinetics of the chemiluminescence signals obtained in 
correspondence of the T-line obtained in the absence of cortisol (white 
symbols) and in the presence of cortisol 1 ng/mL (black symbols) and 10 
ng/mL (grey symbols).  
 
6.3.4 Calibration curve 
 
Using cortisol standard solutions in the range of 0.5 - 100 ng/mL, 
calibration curves were generated. Calibration curves were generated by 
adding known amounts of cortisol standard solutions to saliva cortisol free 
(Fig.6a) and also to PBS in order to evaluate the matrix effect. The 
comparison between the calibration curves is reported in Fig. 6b. Since we 
exploited a  competitive type format, the decrease of the T-line/C-line 
ratio was directly proportional to the amount of the analyte in the sample. 
Repeating calibration curves several times, it was demonstrated a good 
reproducibility with an average of the relative standard deviation 
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associated with each point of the calibration curve of 10% in buffer and 
16% in saliva matrix. The limit of detection (LOD) was estimated as the 
concentration corresponding to the blank T-line/C-line value minus three 
times its standard deviation. The LOD values were 0.3 ng/mL in saliva 
matrix and 0.1 ng/mL in buffer while the dynamic ranges of the method 
extended from 0.3 to 60 ng/mL for saliva and from 0.1 to 60 ng/mL in PBS. 
Even if the LOD value was slightly influenced by matrix effect, the dynamic 
range obtained in saliva was still adequate for evaluating cortisol 
concentrations in human saliva in both normal and pathological 
conditions.  
 
Figure 6: (a) CL images acquired with the smartphone at increasing 
concentrations of cortisol.  (b) Calibration curves for cortisol obtained in 
phosphate buffer and in saliva using the smartphone camera. Images were 
elaborated with imageJ software to quantify the CL signal of the C- and T-
line and plotted as described in material and methods section. 
 
6.3.5 Determination of cortisol in real samples 
 
Saliva samples belonging to 11 subjects were analysed, to further confirm 
the accuracy of the proposed method. The calibration curve obtained for 
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the saliva matrix described by a nonlinear four-parameter logistic 
calibration plot was used for interpolation in order to evaluate the 
concentration of cortisol in real saliva samples. The analysis for each 
sample was repeated four times and the results were compared with 
those obtained using a confirmatory method (Fig. 7a). In Fig. 7b are 
reported chemiluminescence images of LFIA membranes used for analyses 
of salva samples. It was found a good agreement between CL-LFIA and 
commercial ELISA kit results  for all samples. Recovery values were in the 
range from 88% to 116%, and a coefficient of variation below 20% was 
obtained, proving the practical applicability and reliability of the proposed 
CL-LFIA for quantitative determination of cortisol in saliva samples. 
 
 
 
Figure 7: a) Correlation between cortisol concentrations in saliva samples, 
obtained with commercial ELISA kit and the smartphone CL-LFIA 
device. b) CL images of saliva samples from healthy patients at low (I), 
medium (II) and high (III) cortisol concentration.  
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6.4 Conclusion 
 
We have developed and optimized a simple and sensitive device, which 
uses ready-to-use analytical cartridges and a smartphone as a CL imaging 
system to quantify human cortisol level in saliva. We exploited 3D printing 
technology to design and realize accessories that were easily inserted into 
the smartphone and could be adapted for any kind of mobile platforms 
such as smartphone or tablet.  
The use of CL as a detection principle allows to work with simple 
accessories, that compose a mini dark box to prevent interference from 
ambient light, equipped with a small lens aligned with the smartphone 
camera to focus the CL emission from the LFIA strip. Moreover, CL 
detection allows to obtain high sensitivity making it possible to detect and 
quantify cortisol in real saliva samples in the relevant physiological range. 
The method is simple, rapid (total analysis time 30 min) and could be 
performed by unskilled personnel. In addition, the device enabled a point-
of-need analysis approach (i.e. the analysis can be performed directly at 
home), reducing response time and analysis cost. This smartphone-based 
salivary cortisol testing device, could be valuable to assess patient stress 
level as well as other pathology such as depression. This device could thus 
pave the way for a new generation of analytical devices in the clinical 
diagnostic field. 
 
 
118 
 
References 
 
[1] Ballerini D.R., Li X., Shen W.; (2012) Microfluid Nanofluid; 13: 769-787 
[2] Li C.Z., Vandenberg K., Prabhulkar S., Zhu X., Schneper L., Methee K., 
Rosser C.J., Almeid E.; (2011) Biosens Bioelectron; 26:4342-4348 
[3] Martinez A.W., Phillips S.T., Carrilho E., Thomas S.W., Sindi H., 
Whitesides G.M., (2008); Anal Chem; 80, 3699-3707 
[4] Martinez A.W., Phillips S.T., Whitesides G.M., Carrilho E.; (2010) Anal 
Chem; 82: 3-10 
[5] Posthuma-Trumpie G.A., Korf J., Van Amerongen A.; (2009) Anal 
Bioanal Chem; 393: 569-582 
[6] Zhao W., Van der Berg A.; (2008) Lab Chip; 8: 1988-1991 
[7] Qin Z., Chan W.C., Boulware D.R., Akkin T., Butler E.K., Bischof J.C.; 
(2012) Angew Chem; 51: 4358-4361 
[8] Anfossi L.,  Calderara M., Baggiani, C. Giovannoli, C. Arletti, E. Giraudi 
G.; (2010) Anal Chim Acta; 682: 104-109 
[9] Molinelli A., Grossalber K., Krska R.; (2009) Anal Bioanal Chem; 395: 
1309-1316 
[10] Salter R., Douglas D., Tess M., Markovsky B., Saul S.J.; (2006) J Aoac 
Int;  89: 1327-1334 
[11] Cho J.H.,  Han S.M., Paek E.H., Cho I.H., Paek S.H.; (2006) Anal Chem; 
78: 793-800 
[12] Li Z., Wang Y., Wang J., Tang Z., Pounds J.G., Lin Y.; (2010) Anal Chem, 
82:7008–7014 
[13] Xia X.H., Xu Y., Zhao X.L., Li Q.G.; (2009) Clin Chem; 55: 179–182 
119 
 
[14] Zou Z.X., Du D., Wang J., Smith J.N., Timchalk C., Li Y.Q., Lin Y.H.; 
(2010) Anal Chem; 82: 5125–5133 
[15] Fernandez-Sanchez C., McNeil C.J., Rawson K., Nilsson O.; (2004) Anal 
Chem; 76: 5649–5656 
[16] Muhammad-Tahir Z., Alocilja E.C.; (2003) Biosens Bioelectron; 18: 
813–819 
[17] Mirasoli M., Buragina A., Dolci L.S., Simoni, P. Anfossi, L. Giraudi G., 
Roda A.; (2012) Biosens Bioelectron, 32: 283– 287. 
[18] Mirasoli M., Buragina A., Dolci L.S., Guardigli M., Simoni P., Montoya 
A., Maiolini E.,  Girotti S., Roda A.; (2012) Anal Chim Acta;  721: 167– 172 
[19] Roda A., Guardigli M., Michelini, E. Mirasoli, M. Pasini P.; (2003) Anal 
Chem; 75:463A–470A 
[20] Wang X., Hofmann O., Das R., Barrett E.M., De Mello A.J., De Mello 
J.C., Bradley D.D.C.; (2007) Lab Chip; 7:  58–6 
[21] Zangher..  
[22] Pires N.M.M., Dong T.; (2014) Biomed Mat Eng; 24: 15-20 
[23] Caputo D., De Cesare G., Dolci L.S., Mirasoli M., Nascetti A., Roda A., 
Scipinotti R.; (2013) IEEE Sensors J; 14: 2595-2601 
[24] Roda A., Mirasoli M., Dolci L.S., Buragina A., Bonvicini F., Simoni P., 
Guardigli M.; (2011) Anal Chem; 83: 3178–3185 
[25] Ozdalga E., Ozdalga A., Ahuja N.; (2012)  J Med Internet Res; 27: 
14:e128 
[26] Zhu H., Isikman S. O.,  Mudanyali O., Greenbaum A., Ozcan A.; (2012) 
Lab Chip;  13: 51–67 
120 
 
[27] Mudanyaly O., Dimitrov S., Sikora U., Padmanabhan S., Navruz I., 
Ozcan A.; (2012) Lab Chip; 12: 2678–2686 
[28] Sangdae L., Giyoung K.,  Jihea M.; (2013) Sensors; 13: 5109-5116 
[29] Hellhammer D.H., Wüst S.,  Kudielka B.M.; (2009) 
Psychoneuroendocrino;  34: 163–171 
[30] Tlili C., Myung N.V., Shetty V., Mulchandani A.; (2011) Biosens 
Bioelectron; 26: 4382–4386 
[31] Roda A., Girotti S., Lodi S., Preti S.; (1984) Talanta;  31: 895-900 
[32] Roda A., Pasini P., Musiani M., Girotti S., Baraldini M., Carrea G., 
Suozzi A.; (1996) Anal Chem; 68: 1073–1080 
[33] Roda A., Mirasoli M., Venturoli S., Cricca M., Bonvicini F., Baraldini M., 
Pasini P., Zerbini M., Musiani M.; (2002) Clin Chem; 48: 1654–1660 
[34] Marzocchi E., Grilli S., Della Ciana L., Prodi L., Mirasoli M., Roda A., 
(2008) Anal Biochem;  377: 189–194 
[35] Kricka L.J.,  Voyta J.C.,  Broinstein I.; (2000) Methods Enzymol;  305: 
370-390 
 
 
 
 
 
 
121 
 
 
 
 
 
CHAPTER 7 
 
 
Multiwell cartridge with integrated array of amorphous silicon 
photosensors for chemiluminescence detection: development, 
characterization and comparison with cooled-CCD luminograph 
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7.1 Introduction 
 
Lab-on-chip (LOC) devices have recently found progress in the fields of life 
sciences and microtechnology. This devices are characterized by the ability 
of performing analysis of small amounts of sample, employing portable 
and miniaturized analytical instrumentation [1]. However currently there 
are just few LOC devices commercially available and they often require the 
use of laboratory equipment for their operation. Thus the objective of the 
research in this field is directed towards the fully integration of all the 
necessary components into a single analysis tool in order to produce a 
true LOC system [2-5]. 
Bioluminescence (BL) and chemiluminescence (CL), are very suitable for 
the development of LOC system, offering high detectability even in small 
volumes (due to the very low background) and large dynamic range of the 
signal [6-9]. Moreover equipment required for signal detection is rather 
simple, with no necessity for excitation light sources, focusing optics, 
wavelengths selectors, and specific geometry of the measurement cell [9-
10]. However, BL and CL usually require highly sensitive detectors, such as 
cooled CCDs or photomultiplier tubes [11] since the light level emissioni s 
very low and in most cases integrated detectors did not offer suitable 
detectability. In the previous chapter devices based on a cooled charge-
coupled-device (CCD) exploiting a lensless contact imaging approach were 
reported. This detection system, coupled with a microfluidic module, 
allow to perfrom multiplex CL bioanalytical assays achieving high 
detectability that is comparable with those obtained with reference 
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laboratory instrumentation [12-14]. However, although the portability and 
compactness, the detector requires  power consumption that is not 
compatible with the developmet of a real LOC system. An interesting 
alternative for simultaneous detection of different parallel reactions, is 
amorphous silicon (a-Si:H) and its alloys. They are characterized by low 
deposition temperature (<250 °C), that is compatible with a wide range of 
support materials, and moreover thanks to the use of microelectronics 
technologies,  a-Si:H a good candidate for application in microfluidic 
devices [15]. In addition, the a-Si:H physical characteristics make the use 
of this material suitable for different devices, such as electronic switching 
[16], solar cells [17], physical [18] and optical sensors. In particular, a-Si:H 
photosensors provide very low dark currents and a high quantum 
efficiency in the wavelength range from ultraviolet [19] to near infrared 
[20-21]. Thin-film a-Si:H photosensors has been already used [22], for 
measuring the optical absorbance in the UV range [23], fluorescence 
[24,25], or CL signals[26-28]. In this work we proposed a a LOC system 
with integrated photosensors and applied it to two different “model” 
bioassays in order to state the suitability of a-Si:H photodiodes as 
ultrasensitive detection devices for LOC systems. The system is composed 
by an array of 16 a-Si:H photodiodes deposited on a glass substrate (Fig. 
1a) and a PDMS unit containing 16 wells that was placed directly in 
contact with the photosensor in order to obtain an integrated 
microcartridge (Fig. 1b). In this way the CL signal is generated and 
measured in close proximity, providing efficient photon transfer between 
the sample-well and the photosensors and a miniaturization of the 
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system. A custom portable readout electronic board was employed. The 
devices performances were first characterized in terms of sensitivity, noise 
and detectability with different CL and BL systems, comparing the 
analytical performances with reference laboratory instrumentation. 
Finally, the device functionality was successfully tested on two model 
bioanalytical BL (cell toxicity assay) and CL (total antioxidant capacity 
measurements) assays. 
7.2 Materials and methods 
7.2.1 Reagents 
 
Alkaline phosphatase (ALP) from bovine intestinal mucosa, horseradish 
peroxidase (HRP) type VI-A and activated charcoal and ascorbic acid were 
purchased from Sigma-Aldrich (St. Louis, MO). Firefly luciferase (Luc) stock 
solution (5 mg mL−1) was purchased from the ATP Determination Kit 
(Molecular Probes). The Lumiphos Plus CL cocktail for ALP was from 
Lumigen (Southfield,MI) and the Super Signal ELISA Femto CL cocktail for 
HRP was purchased from Thermo Fisher Scientific (Rockford, IL). 
Polydimethylsiloxane (PDMS) Silgard 184 pre-polymer and curing agent 
were from Dow Corning (Midland, MI). The BL cocktail for Luc 
measurements was Britelite plus (PerkinElmer Inc., Waltham, MA). In all 
the microelectronic processes, water for last rinsing was purified with a 
Milli-Q Plus (Millipore, R=18.2 MΩ·cm) ultra-pure water system. All 
solutions were prepared in 0.1 M phosphate buffered saline (PBS) pH 7.7 
employing Milli-Q Plus ultra-pure water. Materials for photolithography 
process (photoresist AZ- 1518, developer AZ351B remover AZ100 and 
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etchants for metals) were purchased from Sigma-Aldrich, while SU-8 2005 
photoresist, its developer and its remover were purchased from Micro 
Resist Technology GmbH (Germany).  
7.2.2 Instrumentation 
 
As a reference instrumentation The Night Owl LB 981 (Berthold 
Technologies, Bad Wildbad, Germany) was employed. To reduce the 
background noise, the system is equipped with a 512×512-pixel back- 
illuminated slow-scan CCD sensor, thermoelectrically cooled to −50 °C. For 
image acquisition and processing The Winlight 1.2 (Berthold Technologies) 
software was used. All images were acquired employing a 4-s integration 
time. Varian Eclipse spectrofluorimeter (Varian Inc., Palo Alto, CA) was 
used for recording chemiluminescence and bioluminescence spectra. 
7.2.3 Photosensor array fabrication 
 
The photosensors are p-doped/intrinsic/n-type stacked structure 
deposited on a glass substrate covered with an indium tin oxide (ITO) layer 
that acts both as transparent window layer for the BL and CL signal and as 
electrical bottom contact for the a-Si:H diodes. Metal films deposited on 
the a-Si:H layers behave both as photosensor top electrode and electrical 
contact lines. Amorphous silicon layers were deposited by a three UHV 
chambers plasma- enhanced chemical vapor deposition (PECVD) system 
(from Glasstech Solar Inc.), metal film were deposited by a BALZERS 510 
vacuum evaporation system while ITO layer was grown by a magnetron 
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sputtering system from Materials Research Corporation (Orangeburg, NY, 
USA). 
The fabrication of the photosensor array was performer through the 
following steps: 
1. Deposition of 150-nm-thick ITO by magnetron sputtering and its 
pattering by wet etching (solution of H2O2:HCl=1:3) for definition of the 
bottom electrode; 
2. Deposition by PECVD of the three a-Si:H layers. The deposited 
thicknesses were 10, 400 and 50 nm for the ptype, intrinsic and n-type 
material, respectively; 
3. Deposition by magnetron sputtering of a three metal layer stack (30 
nm-thick Cr/150 nm-thick Al/30 nm-thick Cr) acting as back electrode of 
the sensors; 
4. Mesa patterning of the device structure by wet and reactive ion etching 
for the metal stack and a-Si:H layers respectively (the area of each 
photodiode is 2×2 mm2); 
5. Deposition of a 5 μm-thick SU-8 layer acting as insulation layer between 
the back metal and the front TCO contacts; 
6. Opening of via holes over the diodes on the passivation layer; 
7. Sputtering of a 100 nm-thick TiW metal layer over the passivation layer; 
8. Patterning of the TiW external contacts for the definition of the back 
contact and the external connection of the photodiodes. 
The photolithographic processes were performed using a TAMARACK 
152R mask-aligner for mask reproduction, a Reactive Ion Etching system 
(from IONVAC PROCESS, Italy) for dry etching of amorphous silicon films 
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and a chemical bench for wet etching of metal films. All the 
microelectronic processes have been performed in a clean room. After 
fabrication, the photodiodes have been individually tested to evaluate 
their electrical and electro-optical characteristics. The photosensor 
current-voltage characteristics were evaluated using a Keithley 236 Source 
Measure Unit (SMU), while the sensor responsivity was measured by using 
a quantum efficiency setup, which includes a tungsten light source, a 
monochromator (model Spex 340E from Jobin- Yvon), a UV-enhanced 
crystalline silicon diode (model DR 2550-2BNC from Hamamatsu) used as 
reference, a beamsplitter and focusing optics (from Melles-Griot). For the 
characterization of the sensor array as a whole and for the subsequent 
experimental part, portable custom readout electronics has been used for 
the simultaneous measurement of the current of the 16 photodiodes [29]. 
The a-Si:H photosensor array was connected to the custom readout 
electronic board using a flex connector. The low-noise readout electronics 
is based on eight ACF2101 dual-channel charge sensitive preamplifiers 
from Texas Instruments that integrate the sensor current providing a 
proportional output voltage that is converted to digital by a MAX180 12-
bit analog to digital converter fromMaxim. The sensor bias is sourced by a 
12-bit digital to analog converter whose output has been buffered with a 
AD8510 operational amplifier to ensure correct driving of the large 
capacitive load represented by the 16 photodiodes in parallel. The entire 
front-end board is controlled by a TUSB3210 microcontroller that also 
provides the USB link to an external computer where a graphical user 
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interface allows to easily operate the entire system from acquisition setup 
to data storage. 
7.2.4 Microwell cartridges fabrication 
 
Coupling a 10-mm-thick black PDMS unit comprising an array of 16 
through holes with the glass support where the 16-photosensor array had 
been deposited a disposable 16-well cartridges with integrated 
photosensors was obtained. Activated charcoal (3 %, w/w) was added to a 
mix of pre-polymer and curing (at a 10:1 ratio(w/w)) in order to obtain 
black PDMS mixture, which was vacuum treated for 15 min to remove air 
bubbles. Then it was casted in a mold containing 16 pillars (2×2 mm) in 
positions corresponding to the photosensors in the array. The 
polymerization took 16 h at room temperature and then the structured 
PDMS was peeled off from the mold and coupled with the glass substrate 
aligning the wells with photosensors and exploiting the sticky nature of 
partially cured PDMS, as previously reported [28]. 
7.2.5 Chemiluminescence measurements 
 
The chip of photosensors was placed inside the CCD-based Night Owl LB 
981 luminograph light-shielded box to ensure dark conditions during the 
experiments and to acquire luminescent signals simultaneously with the 
two instruments. A picture of the measurement setup is reported in Fig. 
1c. The performances of photosensors in providing quantitative 
measurement of the emitted photons down to low light levels was 
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evaluated by generating the calibration curve in a concentration range 
significant for each specific enzyme. 
The background signal was measured for both detection systems in 
absence of luminescent solutions at the beginning of each experiment. For 
each measurement 2 μL of enzyme solution (HRP, ALP, or Luc) at different 
concentrations (buffer for the blank) and 8 μL of the respective 
luminescent cocktail were dispensed in the wells. To ensure that the signal 
measured by the photosensors was not affected by a memory effect due 
to exposure to ambient light [30], the measurements of the luminescence 
signals were performed with a delay of 20 s after the closure of the dark 
box. Consecutive acquisitions of the same integration time for both 
luminograph and photosensors simultaneously enable a comparison of 
analytical performance of the two devices. 
The integration time used for each acquisition was 4 s for images acquired 
with the CCD (with a frame rate of one image every 15s as a trade-off 
between time resolution of process monitoring and data-storage 
requirements) and 3.98 s for the photosensors (enabling a measurement 
of photocurrent every 4 s). The calibration curve was generated by 
plotting plateau values of photocurrent measured during the entire 
luminescent reaction kinetics averaged over three independent 
measurements against enzyme concentration.  
The limits of detection (LOD) were calculated as the enzyme concentration 
whose signal corresponds to three times the standard deviation of the 
blank signal, which is the signal measured in the absence of the enzyme. 
Such standard deviation accounts for electronic noise, photodiodes shot 
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noise, as well as the variation of the low autoluminescence of the CL 
cocktail. 
 
 
Figure 1: (a) View of photosensors array; (b) Schematic overview of the 
16-well microcartridge with integrated a-Si:H photosensors ; (c) 
Measurment setup for comparison between photosensors array and  CCD 
camera. 
 
7.2.6 Cytotoxicity test 
 
A volume of 100 μL of human embryonic kidney cells (HEK293) genetically 
modified to stably express Luc (6,000 cells suspended in liquid culture 
medium) was incubated with 100 μL of dimethyl sulfoxide (DMSO) at 
different concentrations (in the range 2–50 %, v/v in culturemedium, only 
culture medium for the blank) for 90 min at 37 °C. Then, 20 μL of the 
mixture were transferred in the PDMS cartridge wells andphotons 
emission was acquired as reported above (4 s consecutive acquisitions for 
a total of 10 min) after the addition of 20 μL of BL cocktail. 
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7.2.7 Total antioxidant activity measurements 
 
Ten microliters of ascorbic acid solutions (between 0 and 50 μM, only 
buffer for the blank) was dispensed into each well of the PDMS 
microcartridge in duplicate, then 20 μL of Super Signal ELISA Femto CL 
cocktail containing the enzyme HRP (4 pg μL−1) was added. In parallel, 10 
μL of two red grape must extract samples (one ethanol extract and one 
aqueous extract) were assayed in triplicate, upon dilution with water 
(1:500 and 1:100, v/v, respectively). Photons emissions were acquired at 
4-s frame rate for a total of 10 min in order to assess the kinetics of CL 
emission. 
7.3 Results and discussion 
 
A disposable microcartridges for BL and CL-based bioassays integrating 
arrayed a-Si:H photosensors was proposed. Custom portable readout 
electronics has been used for the simultaneous measurement of the 
currents of the 16 photodiodes in order to enable out-of-laboratory 
applications. Custom readout electronics design and sensors architecture 
have been optimized for reaching the required detectability and ensuring 
adequate reproducibility of response between sensors in the array. The 
PDMS unit was coupled with a-Si:H photosensors to obtain disposable 
cartridges containing 16 black wells with clear bottom (40 μL each) in 
which chemical reactions are performed in close proximity to the sensors, 
fabricated on the opposite glass substrate side to avoid issues of chemical 
compatibility. 
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Electrical and electro-optical characteristics of photodiodes were first 
tested. Then, the analytical performance of the arrayed a-Si:H 
photosensors in the measurement of BL and CL emissions was evaluate 
and compared with reference cooled slow-scan CCD-based imaging 
instrumentation.  
Finally, model luminescent bioassays, namely a BL based cytotoxicity assay 
and a CL enzyme-based assay for total antioxidant capacity measurement, 
were used to test their ability to provide real-time measurement of 
evolving BL and CL reactions.  
7.3.1 Photosensor characterization 
 
In order to determine the dark current noise in the operation condition 
and the sensor sensitivity at the different wavelengths, measure of the 
current-voltage (I-V) curve in dark condition and the spectral response in 
the visible range were performed (Fig. 2). Fig. 2a reports the average I-V 
characteristics of three different diodes of the array, measured in dark 
conditions. A value of the dark current in the order of 10−10A cm−2 in 
reverse bias conditions was found for all the photodiodes. The root-
meansquared (rms) dark current noise was calculated to be around 1.6 fA,  
taking into account that the photosensor area is 4 mm2 and that the 
measurements have been taken with a signal bandwidth of 1 Hz. This 
value is below the experimental noise introduced by the experimental 
characterization setup that is around 10 fA. In Fig. 2b are reported 
quantum efficiency curves averaged over three different photosensors of 
the array and it was found a good uniformity of response over the array. 
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In order to enable the use of different BL and CL reactions with the same 
device, the thickness and doping of the different a-Si:H layers have been 
designed in order to achieve a wide spectral response. The firefly Luc-
luciferin ATP Mg2+ BL reaction has a maximum emission at 565 nm. The CL 
reaction catalyzed by ALP in the presence of Lumiphos Plus cocktail 
displays a maximum emission at 470 nm while the luminol/ 
peroxide/enhancer CL reaction catalyzed by HRP has a maximum emission 
at 425 nm. A comparison of the normalized spectra  of the three 
luminescent reactions are reported in Fig.2b. It was observed that all the 
considered luminescence emission spectra match reasonably well with the 
response of the photodiodes, considering the range from violet-blue to 
yellow-greenish light. It is also possible to extend applications also to red-
shifted BL and CL reactions and to tune  spectral response for other 
specific wavelengths of interest by proper sensor design. The photosensor 
responsivity at the emission wavelength of the investigated molecules can 
be derived, according to the QY curve. 
Since the responsivity (R) can be described as :  
R(λ)= QY(λ) λ/1, 240(nm) 
we deduct that the photosensor responsivity is equal to 140, 235 and 320 
mAW−1 for the luminescent reactions catalyzed by HRP, ALP and Luc, 
respectively. 
Comparing the main characteristics of our photosensor with other optical 
detectors integrated in microfluidic chip in terms of responsivity, dark 
level,size and noise level of devices based on both organic and inorganic 
materials, it is possible to find out that the performances of our 
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photosensor are within those of the other proposed systems. Our device 
demostrates a lower responsivity at 425 nm with respect to that reported 
by Pereira et al. [31], but it presents lower dark current and better noise 
performances. The graphene-based photosensor shows very high 
responsivity, due to its internal gain, but it also present a much higher 
dark current, higher thermal budget and more complex fabrication 
process [32]. Finally photodetectors based on organic materials present 
good performances in terms of both responsivity and dark current levels, 
but their fabrication and technology processes are not completely 
assessed [33,34]. 
In the next sections the characteristics of the proposed system are 
discussed in detail in order to evidence its suitability for lab-on-chip 
analysis requirements, since its analytical performances are very close to 
that of cooled backilluminated CCD-based reference instrumentation. 
 
Figure 2: Characteristics measured for three diodes of the a-Si:H array: (a) 
current-voltage curves; (b) normalized quantum efficiency curve. The 
maximum of the quantum efficiency curve, occurring at 580 nm, is equal 
to 0.72. In the same graph, the emission spectra of the luminescent 
reactions studied in this work are shown: each spectrum is normalized to 
its maximum emission value  
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7.3.2 Bio- and chemiluminescence measurements 
 
Three luminescent systems that are widely used in bioanalytical 
applications were used for evaluating performances of the photosensors. 
The luminescent systems are CL reactions catalyzed by HRP or ALP 
enzymes (widely used in enzyme-based assays and binding assays as gene 
probe hybridization and immunoassays), and the BL reaction catalyzed by 
firefly Luc (employed as a reporter gene in recombinant cell-based 
biosensors). A summary of the obtained results is showed in Table 1. 
When the enzyme is employed as a label, the enzymatic substrate is 
added in excess to obtain light emission proportional to enzyme amount 
and, in the chimical luminescence reactions, light detected is a transient 
product of the reaction that is only present while the reaction between 
enzyme and enzymatic substrate is occurring.  
By measuring light emission in parallel with the a-Si:H photosensors and 
the CCD-based luminograph we generated calibration curves for each 
enzyme. It has to be considered that the a-Si:H photosensors were 
employed at room temperature (about 25 °C) in view of their use in a on-
the-field application as well as to avoid cooling down of biological 
reactions that occur on the opposite side of the same glass substrate, 
which would largely affect their kinetics, while the CCD sensor was 
thermoelectrically cooled down to −10 °C, which decreases the 
background signal (both in terms of absolute value and instrumental 
noise) due to the thermal generation of electrons.  
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 a-Si:H photosensors 
array 
CCD-based 
luminograph 
Alkaline phosphatase   
R2 value 0.998 0.997 
Sensitivity 0.012 pA pmol-1 L 29 RLU pmol-1 L 
LOD 30 pmol L-1 19 pmol L-1 
Firefly Luciferase   
R2 value 0.999 0.998 
Sensitivity 0.0067 pA pmol-1 L 30 RLU pmol-1 L 
LOD 500 pmol L-1 160 pmol L-1 
Horseradish peroxidase 
R2 value 0.989 0.999 
Sensitivity 0.45 pA pmol-1 L 1300 RLU pmol-1 L 
LOD 1.6 pmol L-1 0.7 pmol L-1 
 
Table 1: Parameters of the calibration curves obtained for the three 
assayed reactions and two types of detection system employed 
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7.3.3 Alkaline phosphatase 
 
ALP is a enzyme of 160 kDa that is often employed as a marker for CL 
assays employing 1,2-dioxetane derivatives as enzymatic substrates. The 
CL cocktail employed for ALP in this work contains 4-methoxy-4-(3-
phosphatephenyl)spiro [1,2- dioxetane-3,2’-adamantane] disodium salt 
(AMPPD) and an enhancer (which increases the duration and intensity of 
the emission). The enzyme catalytic action on AMPPD consists in 
dephosphorylation of the aryl phosphate with subsequent cleavage of the 
1,2- dioxetane ring and the production of a phenolate in its excited state 
leads to photons emission [35]. The kinetics of photon emission measured 
with on-chip a-Si:H photosensors is reported in Fig. 3. Each measured 
solution contains 2 μL of a 3×10−4 mg mL−1 ALP solution (corresponding to 
2 fmol of deposited enzyme), and 8 μL of Lumiphos plus CL cocktail. In the 
figure is reported the sensor photocurrent calculated as the total 
measured current minus  the dark current value measured before adding 
the enzyme, which was stable for more than 10 min (CV 0.7 %). Upon 
enzyme addition, the photocurrent response rapidly increased during the 
first 5 min and then remained at plateau for at least 5 min (10.8±0.1 pA, 
inset in Fig. 3). The CL signal decreases very slowly to the baseline level in 
approximately 2 h, due to the consumption of CL reagents and/or 
inactivation of the enzyme. The observed behavior was confirmed by the 
reference CCD system and it reflects the typical kinetics of the CL reaction 
of 1,2-dioxetane compounds catalyzed by ALP [36]. All the photodiodes of 
the array shows a dark current around 8 pA.  This baseline value also 
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accounts for the very weak spontaneous light emission of the CL cocktail 
in the absence of enzyme. The intrinsic photodiode current shot noise, the 
preamplifier noise and the switching (kTC) noise contributions cause the 
variance of the baseline signal and they corresponds to the practical noise 
of the system. Results show that the a-Si:H photosensors enables real-
time detection of evolving CL reactions infact they rapidly respond to 
changes in the CL signal and return to dark signal levels upon completion 
of the reaction, without any memory effect. Moreover the amount of data 
corresponding to the entire kinetic curve using 4-s time resolution, 
occupies about 64 kB of memory, while the 480 raw images, acquired by 
the CCD camera every 15 s, occupy at least 235MB (495 kB for each 
frame). 
This has a significant impact on the algorithm complexity and computing 
time for data analysis and also on the data-storage and data-transmission 
bandwidth. Calibration curves were obtained in the range between 5 and 
100 pg μL−1 employing the 1,2-dioxetane-based CL cocktail and in Fig. 4 
are reported the data measured with the a-Si:H photosensors and with 
the CCD-based detector. Both curves present an excellent linearity in the 
investigated range of concentration. Each point referring to the specific 
ALP concentration is taken from the maximum of the kinetic curve with 
respect to the signal baseline, averaged over three different experiments.  
The measured sensitivity of the a-Si:H photodiodes is 38.5 fA pg−1 and the 
calculated LOD at three sigma is 5 pg μL−1 (corresponding to 65 amol of 
deposited enzyme considering  that the measured standard deviation of 
the blank signal is 120 fA. The LOD obtained using the CCD (2.8 pg μL−1) 
139 
 
demonstrates that a-Si:H photodiodes shows equivalent performances 
with state-of-the-art laboratory instrumentation. 
 
Figure 3: Kinetics of photon emission of ALP CL system measured with on-
chip a-Si:H photodiodes 
 
 
Figure 4: Calibration curve for ALP employing the Lumiphos Plus CL 
cocktail. Circle and squares refer to the measurements achieved with a-
Si:H photosensors and CCD camera, respectively.  
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7.3.4 Luciferase 
 
Firefly Luc is one of the most widely used reporter proteins for reporter 
gene-based whole-cell and biosensors for the study of gene expression. 
Wildtype Photinus pyralis luciferase is a 62-kDa protein that in the 
presence of Mg2+, ATP and molecular oxygen oxidizes its enzymatic 
substrate, firefly luciferin, emitting yellow-green light (emission maximum 
∼560 nm). The quantum efficiency of the a-Si:H photosensors is maximum 
at this wavelength, around 0.72, as shown in Fig. 2b. 
Calibration curves for Luc were generated in the range between 20 pg μL−1 
and 2 ng μL−1 employing the luciferin/ATP-based BL cocktail (Fig. 5). It was 
found a LOD of 30 pg μL−1 that corresponds to 1 fmol of deposited 
enzyme, while 10 pg μL−1 was the LOD obtained with the CCD-based 
detection. This extends possible applications to BL-based assays, such as 
recombinant whole-cell biosensors for environmental or life science 
applications and it is the first report about the measurement of Luc signals 
with integrated a-Si:H photosensors. 
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Figure 5:  Calibration curve for Luc employing the Britelite plus BL cocktail. 
Blue and red symbols  refer to the measurements achieved with a-Si:H 
photosensors and CCD camera, respectively 
 
7.3.5 Horseradish peroxidase 
 
Another enzyme widely used in bioanalytical assays is Horseradish 
peroxidase which is characterized by low dimension (44 kDa) and high 
turnover rate. It catalyzes the reaction between a hydrogen acceptor 
(such as hydrogen peroxide) and a hydrogen donor, namely luminol in CL 
systems. Luminol is oxidized producing 3-aminophthalate in its excited 
state and when it decays to the ground state it releases photons with 
maximumemission at 425 nm. Adding some enhancers to the CL cocktail 
such as substituted phenols, substituted arylboronic acid derivatives and 
other molecole it is possible to increase the enzyme turnover number and 
the equilibrium concentration of the key intermediate luminol radical 
anion, providing more intense, prolonged and stable light emission 
[37,38]. 
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In Fig. 6 is reported the calibration curves, obtained for the enzyme HRP 
(between 0.025 and 50 pg μL−1) via CCD camera and photosensors. The 
calibration curves obtained employing the photosensors are 
consistentwith CCD results. Limits of detection of 70 fg μL−1 
(corresponding to 3 amol of deposited enzyme) was found for the 
photosensors, which was only 2.3 times higher than the LOD obtained for 
the CCD measurement in the same experimental conditions and 
consistent with previously reported LOD values [39]. Each curve is the 
average of three independent measurements. The linear response extends 
up to 5 pg μL−1. At higher concentrations it was observed a slight deviation 
from linearity that is probably due to the fact that the CL reagents are not 
in sufficient excess with respect to enzyme amount as previously reported 
[28]. However the dynamic range of the curve covers three orders of 
magnitude of enzyme concentrations. 
By comparing the calibration curves obtained employing different a-Si:H 
photosensor chips produced in different sessions, very high inter-chip 
reproducibility was observed. 
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Figure 6: Calibration curve for HRP employing the SuperSignal ELISA Femto 
CL cocktail. Open and solid circles refer to the measurements achieved 
with a-Si:H photosensors produced in two different fabrication runs and 
acquired with the Keithley 236 SMU and with the custom readout 
electronics, respectively. Squares refer to the measurements achieved 
with the CCD camera 
 
7.3.6 Sensors array characterization 
 
The design of the array of photosensors allows the simultaneous 
measurement of 16 different luminescent reactions. In this way the 
system is suitable for multiplex bioassays in which the reaction areas are 
spatially resolved. It is necessary to verify absence of crosstalk phenomena 
among adjacent photosensors and to ensure that all the photosensors can 
uniformly respond to a given light signal independently on their position 
on the array. 
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7.3.7 Inter-sensor reproducibility 
 
Inter-sensor reproducibility was evaluated by depositing an aliquot of the 
same CL cocktail containing HRP at low (0.2 pg μL−1) and high (2 pg μL−1) 
levels on each photodiode. 
Acquiring the CL signals simultaneously for all the photosensors, it was 
observed a maximum variability of the signal between photosensors of 
3%. 
7.3.8 Crosstalk 
 
The evaluation of crosstalk phaenomenon was performed by pouring HRP 
CL solutions at different concentrations in the highest investigated range 
(between 0.2 and 50 pg μL−1) in one of the black PDMS wells and by 
comparing the signal of the selected site with that of the all neighboring 
sites. 
It was observed that the crosstalk signal between photosensors was well 
below the noise level of the sensors, thus proving that combining the 
design of the array (size and spacing of the photosensors) and the use of 
black PDMS structure for sample confinement is correct making the device 
suitable for the simultaneous measurement of multiple analytes with 
negligible crosstalk between the photosensor.  
 
 
 
145 
 
7.3.9 Model luminescent bioanalytical assays 
 
Applying model BL cytotoxicity assay and a CL total antioxidant capacity 
assay it was demonstrated the applicability of the integrated a-Si:H 
photosensor array to real bioanalytical assays. In these kind of assay, the 
possibility to follow the CL emission in real-time over a large number of 
consecutive acquisitions is crucial for assay performance. 
7.3.10 Bioluminescence cytotoxicity assay 
 
HEK293 cells genetically modified to stably express Luc were treated with 
DMSO at different concentrations (in the range 2–50 %v/v) as a model 
toxic compound. The addition of the toxic compound to the cells 
suspension causes cell membrane disruption, leading to a reduction in cell 
metabolism and viability, thus lowering the BL signal. The BL emission of 
treated cells was normalized accordingly to the blank that was set to 100 
% and plotted against DMSO concentration, as reported in Fig. 7. 
As expected, the decrease in the BL signal attested the toxic effect of 
DMSO and it was found that the half lethal concentration (LC50) of 13 % 
(v/v) DMSO is the concentration that produces a 50 % reduction in light.  
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Figure 7: (a) DMSO effects on the BL signal as a function of toxic 
compound concentration (in the range between 5% and 50%) and 
treatment time (from 30 to 150 min). The signal is normalized respect to 
BL signal measured for the non-treated cells; (b) Normalized cytotoxicity 
curve for DMSO, asmeasured employing a-Si:H photosensors. 
 
7.3.11 Chemiluminescence measurement of total antioxidant capacity 
 
The assay is based on the ability of antioxidants (i.e. compounds with a 
reduction potential lower than that of luminol) to quench the enhanced 
HRP-catalyzed luminol CL reaction [38]. CL emission is quenched as long as 
antioxidants are present in the mixture and it recovers as soon as all 
antioxidants are oxidized. To determine the total antioxidant capacity of a 
sample, the recovery time is employed and compared with the response 
of a standard antioxidant (in this work ascorbic acid).Since  the analytical 
information is given by the time of the 50 % signal, in this type of assay, 
the possibility to simultaneously record in real-time the evolving CL 
reactions is crucial. The evolving signals measured for the CL cocktail in 
the presence of different amounts of ascorbic acid is reported in Fig. 8 
(top). A linear calibration curve was obtained by plotting the time of 50 % 
signal recovery against ascorbic acid concentration. Finally two extracts 
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from red grape juice were assayed, one obtained through extraction in 
water and one in ethanol. Preliminary experiments showed that that the 
optimal dilution factor to obtain signal recovery within 10 min was 1:100 
(v/v) and 1:500 (v/v) for the aqueous and the alcoholic extracts, 
respectively. As shown in Fig. 8 (bottom), for samples containing a mixture 
of different antioxidant compounds, a smooth increase of the CL signal is 
observed as compared with sharp increase of the CL signal observed in the 
presence of the standard antioxidant ascorbic acid. By interpolating the 
time of 50 % signal recovery of each sample on the calibration curve 
previously reported, it was found the total antioxidant capacity of the 
sample expressed as ascorbic acid equivalents, that corresponds to 14 mM 
for the ethanol extract and 3.5 mM for the aqueous extract. These results 
showed, as expected, a higher antioxidants extraction ability of alcoholic 
solutions with respect to aqueous ones. 
 
Figure 8: Real-time monitoring of CL emission of the HRP/CL cocktail in the 
presence of ascorbic acid standard solutions and red grape juice extracts.  
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7.4 Conclusions 
 
In view of the development of integrated of a BL and CL-based LOC device 
that combine the analytical detection system and the transduction into a 
simle chip, the performance of a new photosensors chip was evaluated. In 
order to allow multiplex analyses, the a-Si:H photosensors used in this 
work were deposited on a glass support and patterned in a 4×4 matrix. 
The opposite side of the support was coupled with a multiwell PDMS 
microcartridge that allow to carry out the luminescence reactions in 
positions corresponding to the sensors. The a-Si:H photosensors are are 
amenable to fabrication in different sizes and inexpensive to manufacture. 
For multiplex applications, they can be produced in arrays, in which the 
number of sensors is limited by the size of the glass substrate and their 
density by the crosstalk phenomena, that can be controlled by careful 
design of the array geometry [40]. The photosensors were tested on BL 
and CL-enzyme  based reactions showing a good inter-sensor 
reproducibility within the array, low instrumental noise levels, LOD values 
comparable with those obtained employing reference laboratory 
instrumentation and negligible crosstalk between adjacent sensors. In 
particular, the limits of detection for HRP, AP and firefly Luc enzyme labels 
were found in the order of attomoles to femtomoles and the linearity of 
response extended up to three orders of magnitude making the a-Si:H 
photosensors suitable for analytical applications in BL and CL-based LOC 
devices. 
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The a-Si:H photosensor array are comparable with respect to cooled CCD 
detectors not only regards detectability but even device dimensions and 
costs. Moreover it is important to point out that , while the CCD results 
refer to thermally cooled device, the a-Si:H photosensor performances 
were achieved at room temperature (about 25 °C) showing the suitability 
of the proposed system  for in-the-field applications. 
In addition, the digital memory occupancy of the measured data is 
significantly lower than those of image-based systems, which have 
positive effects not only on the data storage but also on the algorithm 
complexity and computing time for data analysis. 
In the future it will be possible to extend the multiwell cartridge with 
integrated photosensors applicability to the development of rapid 
heterogeneous assays, which require a different microfluidic device. We 
can state therefore that the proposed a-Si:H photosensor array, when 
integrated with microfluidic chips, provides sensitive, compact and 
potentially low-cost microdevices for BL- and CL-based bioassays with a 
wide range of possible applications for in-field and point-of-care bio-
analyses. 
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